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National Health Institute (Italy) OPINION ON THE SCIENTIFIC BASIS OF THE CONCEPT OF THRESHOLD OF 
REGULATION IN RELATION TO FOOD CONTACT MATERIALS 
(expressed on 8 March 1996) 
Terms of reference 
1. In the context of food contact materials, the advice of the Scientific Committee for Food 
(SCF) is requested in relation to the following questions : 
;'. Are the concept and the limit value of the threshold of regulation introduced by the 
United States Food and Drug Administration for the analysis of petitions relating to 
approvals for the use of chemicals as components of food contact materials (equivalent to 
a per diem exposure of 1.5 pg per person) sufficiently justified from the scientific point of 
view ? 
/'/'. If not, what are the criticisms of this concept and the resulting value and, if 
appropriate, which other scientific data are necessary for the Committee to endorse the 
threshold value established by the Food and Drug Administration or any other threshold 
value suggested by the Committee for the application of the threshold of regulation 
concept ? 
iii. If the Committee concludes that current knowledge of toxicology does not permit the 
quantification of the risk for man arising from exposure to chemicals at very low doses, 
could the Committee nevertheless support the view that for exposure at the level of the 
threshold value established by the Food and Drug Administration, the existing data show 
that the risk for man could be considered insignificant ? 
iv. If the Committee concludes that at the level of exposure indicated by the Food and 
Drug Administration's threshold value, the risk for man is not insignificant, could the 
Committee clarify how it presently evaluates the risk for man arising from exposure to 
chemicals at very low doses ? 
The Committee has been requested to give its opinion on these questions by 31 March 1996. 
Background 
Risk assessment of chemicals consumed in small amounts poses problems which are 
common to a number of classes of food chemicals currently under consideration by the 
SCF. 
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Of particular note in this regard are flavourings, food contaminants and migrants from 
food Contact materials. To date, the SCF has examined technical and toxicological 
data on each individual food chemical in its specific context and has formulated advice 
using a case by case approach. However, the large numbers of chemicals occuring, 
used or proposed for use in the areas cited above, the lack of available toxicological 
data on many of them, and the limited scientific resources both for testing and for 
evaluation, are forcing advisory and regulatory bodies worldwide to prioritise tasks 
and devise new strategies in the area of appraisal and regulation of low volume/low 
exposure food chemicals. The situation described above, together with the recent 
adoption of a "Threshold of Regulation" policy by the United States Food and Drug 
Administration (FDA) in relation to food contact materials, and ongoing discussions in 
the Joint FAO/WHO Expert Committee on Food Additives (JECFA) in relation to 
flavourings, have prompted the Commission services to ask the SCF for its scientific 
advice on this matter. 
It would be easy for regulatory bodies to err on the side of caution and continue to ask 
for safety data on all chemicals irrespective of intakes. Such a position might be 
viewed as offering a high level of safety for consumers, but this is not necessarily the 
case; diversion of regulatory resources into scrutinising one particular chemical sector 
in great detail may mean that less attention can be paid to other sectors which may be 
more important to public health. In addition, the Commission and Member States are 
commited to reducing the use of animals in toxicity testing wherever possible. Against 
this background, the Commission services have asked, as have other agencies with 
responsibility for formulating risk management policy, whether, from a scientific 
standpoint, safety data are actually needed in cases where intakes are known to be very 
low. 
Legal frameworks for establishing modalities for risk management of the various 
classes of chemicals traded within the European Union are at different stages of 
development and may differ in their approach. At the present time, the priorities 
imposed on the Commission services by the needs of Member States in the interests of 
international trade are most pressing in the field of food contact materials. For this 
reason, the SCF has been asked in the first instance to advise on risk assessment in 
relation to chemicals consumed in small amounts in the context of food contact 
materials. The Commission services recognise that the SCF, in addressing the specific 
concerns relevant for migrants from food contact materials, will need to consider the 
extent to which some issues can only be resolved by establishing more broadly 
applicable general principles at a later date. 
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The threshold of regulation concept 
5. The FDA has introduced a Threshold of Regulation (TR) policy in its consideration of 
petitions for the use of chemicals as components of food contact materials.
1,
2 In 
essence, the concept behind the TR approach is that there is a level of exposure to 
non-carcinogenic chemicals in the diet below which, even in the absence of toxicity 
data, there is reasonable assurance that no adverse effects would occur in man. In 
practice, by following the TR policy, the FDA will no longer require toxicity data for 
the acceptance of substances for which the petition shows that migration data obtained 
under worst case conditions give a dietary concentration below 0.5 ppb and for which 
there i's no reason, on the basis of the chemical structure of the substance, to suspect 
that the substance is a carcinogen. This dietary concentration of 0.5 ppb equates to a 
maximum intake of l^g/person/day or 0.03μ£^ bw/day for a 50 kg person, 
assuming that a person eats 1.5 kg of solid food and 1.5kg of liquid food per day. The 
FDA has estimated, using quantitative risk assessment (QRA) methodology, that 
should a substance which is in fact a carcinogen be inadvertently accepted, then at the 
level of exposure established by the TR value, there would be an 85% probability that 
the lifetime cancer risk to man would not exceed one in a million. This level of risk is 
considered by the FDA to be tolerable and reflects the widely held pragmatic view that 
it is impossible to protect against every unforeseen and exceptional risk from low level 
exposure to chemicals. The FDA's analysis, which now covers over 500 known 
carcinogens, did reveal several chemicals which could pose a risk greater than one in a 
million if present in food at 0.5ppb (e.g. anatoxin Bl and 2,3,7,8-tetrachlorodibenzo-p-
dioxin),
3 but these were few and illustrate the point alluded to above that it is 
impossible to make a practical recommendation for a threshold of regulation if absolute 
guarantees of no harm are required. 
Risk asessment versus risk mangement 
The Committee noted the clear terms of reference given by the Commission and that 
the SCF's remit in this task was limited to advice in relation to risk assessment of 
chemicals to which there may be only low exposures. Risk management should not be 
considered since this is the duty of the Commission and Member States. Risk 
assessment involves evaluation of the inherent toxicity of chemicals and estimation of 
the probability of harm to human health under known conditions of exposure. Risk 
management involves deciding on the acceptablity of any predicted level of risk and 
what actions, if any, need to be taken to reduce those risks. The FDA, in developing 
and implementing a threshold of regulation policy as a risk management tool, has 
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undertaken both roles since risk assessment and risk management fall within their 
jurisdiction. 
In the chemicals field, a clear distinction between risk assessment and risk management 
is often difficult to draw; risk assessment of chemicals is a probabilistic not an actuarial 
exercise, involving many uncertainties, and so considerable elements of value 
judgement are called into play. 
For example, existing approaches utilised by the SCF in advising the Commission on 
acceptable levels of intake for food additives already embody an element of judgement 
in selection of the size of safety factors that are deemed acceptable to be applied to no-
effect levels derived from toxicity studies in animals or humans. Similarly, in 
addressing the questions put to the Committee by the Commission in the terms of 
reference set out above, the SCF must comment on QRA methods devised for 
carcinogens, which often use "worst case" assumptions. This already implies an 
element of selection and rejection of particular scenarios. However, a distinction 
between the processes of risk assessment and risk management should as far as 
possible be maintained if the essential scientific basis of the risk assessment process is 
not to be compromised. In observing this distinction, the role of the SCF must 
necessarily be limited to advising on whether there is sufficient scientific evidence to 
define a "threshold of no toxicological concern", rather than extending to a discussion 
of the issues in terms of a threshold for regulation. 
The validity of the threshold concept 
The concept of thresholds for manifestations of toxicity other than genotoxicity and 
genotoxic carcinogenicity has been accepted and applied by the SCF over many years. 
Indeed, it is the basis for the setting of Acceptable Daily Intakes (ADIs), Tolerable 
Daily Intakes (TDIs) and Provisional Tolerable Weekly Intakes (PTWIs). In the 
absence of human data, these are established by the application of a safety factor to the 
no-observed-adverse-effect level (NO AEL) determined empirically in a range of animal 
tests. The design of the specified studies is laid down in international guidelines. The 
NOAEL identified in the core study among these tests is regarded as that level at and 
below which there are no observable effects of toxicological concern. The principle 
has been applied routinely on a case by case basis, both for non-carcinogens and also 
for carcinogens where a consideration of the mechanism indicated the absence of a 
genotoxic mode of action. The key novel aspect of the present request by the 
Commission for advice is the possibility of establishing a single, general threshold for 
toxicological concern and of including within this carcinogens with a potentially 
genotoxic mechanism of action. It is necessary by a stepwise approach to address the 
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concept of such a threshold and, if considered scientifically valid, to address the level 
of exposure to which the concept might apply. 
I. Chemicals other than genotoxic carcinogens 
8. The existence of thresholds for toxicity of compounds other than genotoxic 
carcinogens is widely accepted within the scientific community and is utilised in very 
practical ways by regulatory bodies. This acceptance has been based on the observed 
non-stochastic nature of many dose-response relationships, described graphically by 
the characteristic sigmoid-shaped dose-response curve, in which no overt toxic effects 
are observed at the lower doses. 
These empirical observations have formed the basis of one of the most fundamental 
principles in oxicology that (to paraphrase Paracelsus) it is the dose which makes the 
poison. Nowadays, empirical observations of thresholds are often supported by 
mechanistic knowledge which confirms a scientific basis for particular thresholds. This 
may include, for example, toxicokinetic information, in particular, limitations on 
absorption, the ability to detoxify by metabolism and conjugation and to excrete 
rapidly certain toxic compounds and their intermediates, such that little or no 
biochemical or tissue disturbance occurs; information on receptor-ligand interactions at 
target sites, which may require a critical concentration of toxic molecules to be 
achieved before a toxic event is triggered; and knowledge of defence and repair 
mechanisms which enable cells to cope with short-lived biochemical and structural 
disturbances, such that no overt manifestation of toxicity occurs. 
9. While the concept of thresholds has been widely accepted in toxicology, the ability of 
experimental studies to accurately determine thresholds has certainly not gone 
unquestioned. The life-span of animals compared to man, the numbers of animals used 
in a study, the choice of dose levels and their spacing relative to one another, the level 
of detail with which potential changes are examined (organ, tissue, cell or molecular 
level, by gross pathology, histopathology, electronmicroscopy, and physiological, 
functional or biochemical parameters), and the appropriateness of the statistical tests 
applied can all influence the ability of a study to determine the true biological no-effect 
level. Because this is well recognised, techniques have been developed which avoid 
identifying a NOAEL and instead utilise all the dose-response data to define a dose 
which causes a small but measurable increase in effect,
4 as for example in the US 
Environmental Protection Agency's benchmark dose (BMD) concept.
5 For risk 
assessment, either an uncertainty factor is applied to the BMD to derive a reference 
dose (RfD) which is then used in the same way as an ADI or TDI, or a calculation is 
made of the margin between the BMD and actual/likely human exposures. This may be 
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particularly valuable in risk assessment of unavoidable environmental contaminants, or 
with drugs where the margin of safety between therapeutic doses and undesirable 
toxicity may be quite small. A "margin of safety" approach (i.e comparisons of low 
effect levels with exposures) may also be useful in cases such as flavourings, where 
there are few toxicological data. However, in the wider field of food chemical safety, 
where usually a safety factor of 100 is applied to a NOAEL, a small imprecision in an 
experimentally observed NOAEL does not critically influence the overall risk 
assessment. 
10. In the context of discussing whether it is possible to define a threshold of no 
toxicological concern for non-genotoxic endpoints, the Committee noted that several 
useful publications and databases are in existence (though not all of them yet available 
for detailed scrutiny) which have compiled critical NOAELs for large numbers of 
chemicals.
6"'
0 Most of these databases are drawn from acute, sub-chronic and chronic 
studies in rodents. A key consideration therefore is whether endpoints which might 
give rise to important low dose effects, such as neurotoxic, immunotoxic, 
endocrinologie and developmentally toxic events, are adequately covered by the 
studies which make up the bulk of these databases. 
To ensure that these aspects are fully taken into consideration and that any threshold 
chosen would provide an adequate safety margin on their NOAELs, it would be 
desirable to develop an additional database which focuses on data on the above 
endpoints. However, it is recognised that the construction of an up-to-date database 
would require considerable resource and, even with that resource, could not be 
achieved within the timescale set by the Commission for the initial advice of the SCF in 
relation to food contact materials (March 1996). 
11. As a preliminary step to any future work, the SCF Task Force on Threshold of 
Regulation has carried out statistical analyses" of the distributions of TDIs and PTWIs 
available from SCF reports on 84 monomers and 276 additives used in food contact 
materials,'
2'
1
6 the 180 ADIs available from the reports of the Joint FAO/WHO Meeting 
on Pesticide Residues,'
7 and the 131 ADIs and PTWIs for food additives and general 
contaminants set or endorsed by the SCF. While these were not expected to yield 
particularly low values, it would in any event be necessary to verify that any particular 
threshold value which might emerge from future discussions was not in conflict with 
any ADI, TDI or PTWI already established by the Committee. For this exercise they 
were compared with the approximate intake equivalent (0.03 μg/kg bw/day) of the TR 
value of 0.5ppb in the diet adopted by the FDA. The results are shown in Table 1. 
The analyses showed that in no case would the application of the FDA TR value have 
led to a less conservative outcome for risk assessment (i.e. the level of exposure 
indicated by the TR value was always less than that indicated by the ADI, TDI, or one-
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shown in Table 1. The analyses showed that in no case would the application of the 
FDA TR value have led to a less conservative outcome for risk assessment (i.e. the 
level of exposure indicated by the TR value was always less than that indicated by the 
ADI, TDI, or one-seventh of the PTWI.) With a few exceptions, there was always an 
appreciable margin between the level indicated by the TR value and the 
ADI/TDI/PTWI. The exceptions were some pesticides. Ninety-six percent of 
pesticide ADIs were higher than 10-fold above the TR value, but in the cases of 
aldrin, dieldrin and heptachlor, having ADIs of 0.1 μg/kg bw/day, the margin was 
only 3.3-fold, while in the cases of endrin, terbufos and propylenethiourea, having 
ADIs of 0^g/kg bw/day, the margin was 6.7-fold. In the case of monomers for food 
contact materials, all TDIs were higher than 100-fold above the TR value and in the 
case of additives for food contact materials, all were higher than 10-fold above the TR 
value. In the case of food additives and general contaminants, all except one were 
higher than 100-fold above the TR value. Mercury was only 20-fold above the TR 
value. 
Further analyses using tolerance limits estimated with a 95% confidence level for the 
lower percentiles of the statistical distributions of ADIs/TDIs/PTWIs suggested that if 
the application of the FDA TR value were to be extended to unknown compounds 
falling within the classes of chemical represented by these distributions, the risk that it 
would lead to exposures higher than any ADI or TDI that might be set was small 
(ranging from less than two in a thousand to less than one in a million). 
12. While the Committee would wish to review the results of more recent studies on key 
non-genotoxic endpoints before proposing a level of no toxicological concern (as 
explained in paragraph 10 above), it is the Committee's provisional view that, at the 
level adopted by the FDA as the basis of a threshold of regulation, few, if any, non-
genotoxic and non-genotoxic carcinogenic effects are likely to be expressed and the 
margin of safety for most such effects is likely to be adequate. 
Exceptions to this might be fat-soluble substances which bioaccumulate and/or act 
through specific receptors, such as 2,3,7,8-tetrachloro-dibenzo-p-dioxin and 
hormonally active substances; such substances might still exhibit toxicity if taken 
over a period of time at levels below the FDA threshold value. The Committee also 
notes that it might be worthwhile considering whether a separate threshold could be 
proposed for food chemicals which are satisfactorily demonstrated to be non-
genotoxic, since this may be useful and, in the present state of knowledge, may be 
easier to define than a single overall threshold of no toxicological concern covering 
both non-genotoxic and genotoxic effects. While such a threshold may be useful for 
the application of regulatory policy in relation to migrants from food contact 
materials, certain other contaminants, and perhaps some flavourings, the Committee 
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II. Chemicals which may be genotoxic carcinogens 
13. The issue of thresholds for genotoxicity and genotoxic carcinogenicity is a central area 
of debate in regulatory toxicology. Many scientists feel intuitively that there are 
probably levels of exposure below which no genotoxic effects would be manifest. But, 
from a formal point of view, it is necessary to consider whether, at this point in time, 
there is sufficient scientific evidence to conclude that there is a level of exposure to 
genotoxic substances below which the likelihood of adverse events resulting in either 
heritable germ cell mutations or cancer from somatic cell mutations could be excluded 
with reasonable certainty. Unlike non-genotoxic endpoints where we can draw on 
strong empirical evidence for thresholds, there are as yet only two experimental studies 
on low-dose administration of genotoxic carcinogens to large numbers of animals and 
neither of these provided clear evidence of a measurable threshold.
181
9 
In addition, the in vivo relationship between carcinogen dose and DNA damage has 
been found linear over a wide dose range, spanning several orders of magnitude, some 
examples being anatoxin Bl, benzo(a)pyrene, acetylaminofluorene, 2,4-diaminotoluene 
and cyclopentapyrene.
20"
2
5 
14. A further complication in the issue of thresholds for genotoxic carcinogens is that the 
experimental observations on which judgements have to be based are subject to 
statistical uncertainties, not least because they have to be made against a background 
incidence of tumours which may be unrelated to exposure to the chemical under 
consideration. From good experiments it is possible to define statistically a level of 
exposure which fails to cause any significant increase in particular tumour rates above 
background rates in controls. At the same time, because one can never prove a null 
hypothesis, it is impossible to say categorically that exposures at or below this level to 
the chemical under consideration would never give rise to tumours caused by that 
chemical. With the exception of the studies already cited,
181
9 experimental animal 
studies, with their relatively limited numbers of animals, are not designed to establish 
whether or not thresholds exist. 
15. As an alternative to the goal of setting a threshold for expression of genotoxic effects, 
the occurrence of a carcinogenic outcome can be viewed as a probabilistic event. The 
fact that, for both genotoxic and non-genotoxic carcinogens, there is a strong dose-
response relationship at overtly carcinogenic doses is indirect evidence that at very low 
doses risks for genotoxic carcinogens probably do become vanishingly small. 
However, it should be stressed that, from a theoretical point of view, such a reduction 
in probability does not equate to a threshold in the strict sense of the word since it is 
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16. Similarly, it is possible to express the issue of carcinogenic risks at very low doses in 
terms of whether they can be considered negligible risks. It is noted that some 
governments and regulatory bodies have used mathematical QRA methodology, 
applied to rodent carcinogenesis bioassays, to derive by extrapolation a dose or level of 
exposure at which it is predicted that there will be less than a 1 in 10
6, 1 in 10', or 1 in 
10
4 lifetime risk for man of developing cancer. Such a dose is sometimes referred to 
as a virtually safe dose or acceptable exposure level. Using such estimates it can then 
be argued, for example, that exposure to a particular chemical at levels normally 
encountered in the diet is less risky (e.g. in terms of likelihood of death) than some 
naturally ocurring chemicals in the diet or some other daily activities. However, it 
should be noted that decisions on whether particular exposure levels are "acceptable" 
or whether risks are "negligible" or "vanishingly small", involve the risk management 
elements of social and political value judgements, not just scientific considerations. 
17. To date, the SCF has advised on genotoxic carcinogens in the diet (such as 
contaminants and natural toxicants) on a case by case basis using a "weight of 
evidence" approach. 
This entails forming a judgement about likely potency in man based on all the available 
toxicokinetic, toxicodynamic and toxicological effects information. In this approach, 
aspects such as the structure of the chemical, the extent of absorption and retention, its 
comparative metabolism in test species and man, its range of activity in tests for 
genotoxicity, preceeding biochemical and pathological changes in tumour target 
organs, time to tumour formation, location and number of different tumour sites, the 
number of species and sexes affected, etc, are all taken into account. Such an 
approach yields a relative and qualitative assessment of carcinogenic risk, rather than a 
precise quantitative estimate. QRA methodology on the other hand, which does yield a 
quantitative estimate of risk, utilises only the carcinogenicity bioassay results. The 
SCF has not so far used QRA methodology and should the SCF decide to do so in the 
present context, it is recognised it would have repercussions in other fields of SCF 
activity. The Committee is aware that there is no scientific consensus on the validity of 
the presently available QRA methodology in predicting cancer risks and there are 
serious criticisms concerning the results which the mathematical models produce:
2
6 
they may bear only a superficial resemblance to the biological processes underlying 
carcinogenesis as presently understood; predictions of risk for the same chemical may 
differ by several orders of magnitude depending on the model used; most models are 
conservative and could result in over-regulation of chemicals actually posing no risk 
(an outcome of considerable consequence for naturally occuring contaminants and 
some existing synthetic chemicals); and the quoting of a precise figure may convey to 
the public and to those involved directly in risk management a spurious sense of 
accuracy for the risk estimate. Moolenaar
2
7 has summarised the policy of the US EPA, 
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for example, which uses QRA methodology, as follows: "EPA policy states that it is 
not currently scientifically possible to accurately predict risk to humans from 
experimental data, so no attempt is made to do so. Instead, a plausible upper bound to 
risk is estimated. EPA states the true risk is expected to be between zero and the 
upper bound." The SCF does however recognise that, insofar as the most frequently 
used QRA model, the linearised multistage model, is acknowledged to be conservative, 
to regulate on the basis of any threshold of toxicological concern derived from it may 
well ensure protection of public health from the majority of carcinogenic risks in the 
diet. 
Conclusions and recommendations 
18. The Committee offers the following views on the questions as posed by the 
Commission in the terms of reference. 
19. Qi. Are the concept and the limit value of the threshold of regulation introduced by 
the United States Food and Drug Administration for the analysis of petitions relating 
to approvals for the use of chemicals as components of food contact materials 
(equivalent to a per diem exposure of 1.5 pg per person) sufficiently justified from the 
scientific point of view ? 
Qii. If not, what are the criticisms of this concept and the resulting value and, if 
appropriate, which other scientific data are necessary for the Committee to endorse 
the threshold value established by the Food and Drug Administration or any other 
threshold value suggested by the Committee for the application of the threshold of 
regulation concept ? 
The Committee concludes that the concept behind the threshold of regulation policy, 
that is to say, the proposition that there is a level of exposure to non-carcinogenic 
chemicals in the diet below which, even in the absence of toxicity data, there is 
reasonable assurance that no adverse effects would occur in man, is a sound one. 
However, the Committee considers that, in the context of the Commission's current 
request for advice on the threshold of regulation concept in relation to food contact 
materials, before any firm conclusions could be reached on a dietary limit value for a 
threshold of no toxicological concern for non-genotoxic endpoints, it would be 
necessary to conduct an up-to-date review of existing data covering important 
endpoints of concern which may give rise to effects at low doses, such as neurotoxic, 
immunotoxic, endocrinologie and developmentally toxic events. 
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To facilitate progress in future work on this subject the Committee therefore 
recommends that a database be developed that is amenable to interrogation and 
exploration, which focuses on the above endpoints. 
20. It may be worth considering, as a second step, whether it is desirable to set two 
separate threshold values - one for substances known to be non-genotoxic and a 
second for substances whose genotoxic potential is unknown. If so, then the setting of 
a threshold of no toxicological concern for non-genotoxic substances would need to 
be informed by development of the targeted database recommended above, and would 
be achievable in the short-term. The possibility of setting of a threshold for substances 
whose genotoxic potential is unknown would undoubtedly require further fundamental 
studies addressing the issue of thresholds for the expression of genotoxic activity, and 
may or may not be achievable in the long-term. 
21. Qiii. If the Committee concludes that current knowledge of toxicology does not 
permit the quantification of the risk for man arising from exposure to chemicals at 
very low doses, could the Committee nevertheless support the view that for exposure 
at the level of the threshold value established by the Food and Drug Administration, 
the existing data show that the risk for man could be considered insignificant ? 
Qiv. If the Committee concludes that at the level of exposure indicated by the Food 
and Drug Administration's threshold value, the risk for man is not insignificant, 
could the Committee clarify how it presently evaluates the risk for man arising from 
exposure to chemicals at very low doses? 
Were a pragmatic decision to be taken by the Commission and Member States to 
utilise the FDA TR value of 0.5ppb in the daily diet in order to manage the present 
outstanding problems in the area of food contact materials, such a threshold would, in 
the Committee's provisional view, protect against most types of toxicity other than 
genotoxic ones. Exceptions might be substances which are toxic following repeated 
low levels of exposure due to bioaccumulation and/or interaction with specific 
receptors. The Committee would be able to give a definitive view on this once the 
work recommended in paragraph 22 was available. However, the remaining risks 
from exposure to chemicals at very low doses are most likely to be heritable and 
carcinogenic risks from genotoxic chemicals. Present scientific knowledge does not 
allow a definitive conclusion as to whether or not a true threshold exists for genotoxic 
carcinogens. Given this is the case, some bodies have adopted probability approaches 
to low dose exposures to carcinogens as the only methods available at present which 
provide quantitative predictions of risks for man. However, in the Committee's view, 
the mathematical methods currently used for extrapolating from experimental animal 
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studies are not sufficiently scientifically well-founded to persuade it that they provide a 
valid basis for estimating the true risk from very low dose exposures. 
Nevertheless the Committee recognises that the linearised multistage model favoured 
in the USA and used by the FDA to derive the TR figure of 0.5ppb incorporates a 
number of conservative assumptions, aimed at defining an upper bound to low-dose 
risk estimates, and thereby probably provides protection against a large number of 
genotoxic carcinogens. 
22. The SCF's previous considerations of genotoxic carcinogens present as contaminants 
in food have been largely based on a weight of evidence approach and, in the case of 
unavoidable contaminants, SCF recommendations have urged reduction of the 
concentration of the contaminants to the lowest levels technologically achievable or to 
levels based on analytical limits of detection. The Committee recognises that this is a 
pragmatic rather than a risk-based approach and whilst it is defensible, in that reducing 
levels of genotoxins in food as low as possible should bring health benefits, it would be 
desirable to develop methods which will enable the Committee to make risk-based 
assessments in the future, utilising all the biological evidence. Such risk-based 
assessments would be of more assistance to the Commission for framing of any 
necessary legislation which at present must be based on the constantly moving target of 
technical capability. To this end the SCF recommends that it be given the resources to 
appraise new developments in risk assessment methodology and, should suitable and 
robust methods emerge, work towards an appropriate framework of guidelines on how 
such methods might be applied to the various areas of the Committee's activities. 
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Table 1 : Summary of comparisons of ADI's, TDI's and PTWIs' with the intake 
permitted by the US FDA Threshold of Regulation 
Fold above TR
2 
>3.3 
>10 
>100 
>1000 
>10000 
>100000 
Pesticides 
(180) 
100% 
96% 
77% 
36% 
4% 
1% 
Food Contact 
Monomers 
(84) 
100% 
100% 
100% 
95% 
37% 
10% 
Additives 
(276) 
100% 
100% 
95% 
68% 
40% 
12% 
Food Additives 
& contaminants 
(131) 
100% 
100% 
99% 
98% 
92% 
69% 
Notes  1. PTWIs have been divided by 7 to give daily figure 
2. TR taken as equivalent to 0.03 μ§/\ί£ bw/day (see text) 
3. Numbers in parentheses indicate number of substances 
in each category 
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TALLOW AND DI-CALCIUM-PHOSPHATE IN RELATION TO BOVINE SPONGIFORM 
ENCEPHALOPATHY 
(Expressed on 15 April 1996) 
Terms of reference 
The Committee was asked to advise the Commission on the extent to which current 
knowledge of the conditions required to deactivate the agent(s) responsible for spongiform 
encephalopathies in cattle (BSE) allows specification of treatments for processed food 
products, which will assure the absence of such agents in processed food products derived 
from bovine tissues, especially gelatin, tallow and di-calcium phosphate. 
Background and Discussion 
The Committee noted that since its previous discussion on this issue (100th Meeting of the 
SCF, 8 March 1996), the British Government announced (20 March 1996) new information 
relating to a possible link between BSE and Creutzfeldt-Jakob-Disease (CJD) in humans. 
Following this announcement the Commission, on 27 March 1996, decided on its emergency 
measures to protect against BSE
1. 
The Committee examined the data made available to it which mainly concerned gelatin. The 
information on gelatin included interim data from an inactivation study applied to different 
steps of the production processes. No information was provided to the Committee in a form 
allowing formulation of an opinion on tallow or di-calcium phosphate at the present time. 
The Committee also noted recent considerations made by the Scientific Veterinary Committee 
and the Scientific Committee on Cosmetology on related issues. 
The Committee acknowledges the overall approach which considers the source material, the 
preparation processes and the routes of exposure. At present the Committee has very limited 
material in hand to allow evaluation of the production processes or the type and extent of 
exposure to gelatin, tallow and di-calcium-phosphate from food. 
The Committee was informed about manufacturing processes for gelatin as described in an 
interim documentation of the Gelatin Manufacturers of Europe (GME) for submission to the 
German Federal Institute for Pharmaceutical and Medicinal Products ("Die BSE-Sicherheit 
von Pharmagelatine aus Rohstoffen vom Rind", status 28 July 1994). Our understanding of the 
'Commission Decision 96/239/EC of 27 March 1996, OJ L 78, 28.03.1996 
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interim information provided by GME is that gelatin for food use produced in Europe is all 
made by the processes described in that document; that these processes use source materials 
regarded to be of very low or no infectivity; that they do not use any source materials from the 
UK and, should by some rare chance a small amount of infective material from elsewhere be 
included, its infectivity would be reduced by several orders of magnitude due to dilution within 
the large production batches and by the heat and the chemical reactions involved in the 
processes. It was noted by the Committee that scrapie was used as a surrogate for the BSE 
agent. 
Conclusion 
Based upon current incomplete knowledge regarding BSE and its possible transmission to 
humans and the uncertainty about the inactivation of the infective agent, the Committee at 
present is only able to advise that bovine source materials for these products are to be taken 
only from geographical areas where BSE does not occur in epidemic proportions. 
The Committee urges that data required for a scientifically based risk assessment be generated 
by relevant bodies. Further research is needed especially to develop specific, sensitive and 
rapid methods for the detection of the causative agent in biological materials. 
18 Reports of the Scientific Committee for Food (Thirty-ninth Series) OPINION ON THE USE OF OZONE FOR THE REMOVAL OF UNSTABLE 
ELEMENTS SUCH AS ERON, MANGANESE AND ARSENIC FROM 
NATURAL MINERAL WATER 
(Expressed on the 7 June 1996) 
Terms of Reference 
To examine the safety of use of the ozone enriched air treatment 1 of certain natural mineral 
waters^ 
Background 
Until about 1970, mineral waters classified by the industry as "very sour" and from which 
unstable elements·* such as iron and manganese could not be removed by oxygenation and 
filtration, were oxygenated and stored in open tanks. After several days, insoluble iron oxide 
hydrates and calcium carbonate precipitated and the supernatant was decanted, bottled and 
carbon dioxide was added. 
This traditional process is disadvantageous as the removal of iron remains incomplete and has 
virtually no effect on the concentration of manganese or arsenic. The decrease in the 
concentration of calcium and hydrogen carbonate ions changes the composition of the water 
as regards the essential constituents which give it its properties and, furthermore, mineral 
water kept for a long time in open tanks is very often objectionable from the microbiological 
point of view. 
Subsequently, ozone treatment was found to be much more efficient for the treatment of this 
class of mineral waters whilst maintaining their essential organoleptic characteristics. Excess 
ozone would disappear without leaving residues and, at that time reaction products were more 
or less unknown. 
Discussion 
Problems linked to the use of ozone enriched air in the treatment of natural mineral waters 
arise from the formation of reaction by-products, especially bromate and bromoform. The 
Committee concluded in its opinion issued in February 1989 on the use of potassium bromate 
as a flour treatment agent, that potassium bromate is a genotoxic carcinogen and that its use 
As mentioned in Article 1 of the Commission's proposal for a Directive modifying Directive 80/777/EEC on the exploitation and 
marketing ofnatural mineral waters (O.J. C314 11.11.1994) 
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for that purpose should be discontinued (26th Series). Since the advice of the Committee is 
that levels of genotoxic substances should be kept as low as possible, this would impair the use 
of ozone if there were no means to suppress side reactions. Generally, the use of ozone 
should be limited to those waters which cannot be treated otherwise. 
Calcium carbonate saturation·* (1) (2) could be a suitable criterion to restrict the oxidation 
of unstable elements by ozone enriched air to those natural mineral waters from which e.g. 
iron, manganese and arsenic cannot be sufficiently removed. The pH of the aerated water 
must at least exceed 7 for complete removal of iron and 7.2 for removal of manganese (3) 
(4). At lower pH values of calcium carbonate saturation·* , calcium carbonate, and 
occasionally calcium magnesium carbonate, will be precipitated. This would alter the 
composition of the water as regards the essential constituents which give it its properties. 
In order to prevent these disadvantages, natural mineral waters having a pH value of 
calcium carbonate saturation below 7.2 could be treated by ozone enriched air. 
Oxidation processes using ozone enriched air should be carried out in closed systems to 
achieve safe operation (5). The ozone reaction time in reaction tanks should be limited 
with regard to flow rates, thus providing a means to allow effective control and to 
minimise undesirable side reactions. Furthermore, side reactions would be suppressed if 
the pH is reduced during the reaction period by adding carbon dioxide under pressure (6) 
(7). Excess ozone should not remain in the treated mineral water although it will rapidly 
decay. After separating iron and manganese oxide hydrates, the water should therefore be 
filtered over granular activated carbon to remove residual ozone. 
The dosage of ozone enriched air depends on the composition of the natural mineral water 
and primarily on the ozone demand of the bivalent iron and manganese. The ozone dosage 
should be twice the quantity calculated stoichiometrically in order to compensate for the 
decomposition of the ozone. 
Apart from a limited ozone reaction period and a limited dosage of ozone, the most 
effective measure to suppress the formation of undesirable by-products is a reduction of 
pH by an additional dosage of carbon dioxide under pressure during the reaction (8). 
Since it is not possible to predict the optimum level to which the pH should be reduced, it 
is essential to control the efficiency of the procedure by monitoring the formation of 
undesirable by-products. 
A Term used by the natural water industry 
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Conclusion 
The Committee recognises that the ozone treatment of natural mineral waters may lead to the 
formation of undesirable by-products. It therefore recommends that the following conditions 
be met to minimise side reactions which may generate hazardous substances: 
The treatment with ozone enriched air of natural mineral waters should be restricted to waters 
recognised as natural mineral waters and having a pH value of calcium carbonate saturation·* 
below pH 7.2. 
The amount of ozone used for the treatment of natural mineral waters may not exceed twice 
the demand necessary to oxidise the unstable elements, e.g. bivalent iron, bivalent manganese 
and trivalent arsenic. 
The ozone treatment of natural mineral waters should not exceed three minutes. 
In order to optimise the efficiency of the ozone treatment, treatment plants must be of the 
closed system type. 
Residual ozone must be removed by filtration on granulated activated carbon following the 
removal of iron and manganese. 
The pH of the natural mineral water must be decreased during the reaction with ozone by 
adding excess carbon dioxide to a level where any side reactions could take place only to a 
negligible extent. 
The Committee concluded that residual ozone and the concentrations of undesirable by­
products should be in the range of technical unavoidability, should be undetectable by the best 
available analytical methodology and should be below the levels given below. 
The Committee is informed that, at the present time, the following limits of quantification are 
achievable but expects that they will be progressively reduced in line with advances in 
analytical chemistry. 
Concentration of residual ozone (9) :<50μg/l 
Concentration of bromate ( 10) ( 11 ) : < 1 pg/1 
Concentration of bromoform (12) :< ^g/l 
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(RESPONSE TO COMMENTS OF THE FRENCH AUTHORITIES) 
(Opinion expressed on 7 June 1996) 
Terms of reference 
To consider a number of questions raised by the French authorities concerning the SCF 
opinion on dimethyldicarbonate (DMDC). 
Background 
DMDC was evaluated by the SCF at its 66
t
n meeting (March 1989) and considered acceptable 
for the cold sterilization of soft drinks and fruit juices at levels of addition up to 250 mg/1. This 
decision was published in the 26th Series of Reports of the SCF in 1992 (2). In the Common 
Position (EC) No 17/94 adopted by the Council on 10 March 1994 (1) on food additives other 
than colours and sweeteners, DMDC (E 242) is proposed as preservative for non-alcoholic 
aromatised beverages, alcohol free wine, and liquid tea concentrates at levels of addition of 
250 mg/1 maximum with residues not detectable. 
The FDA cleared a food additive petition for the use of DMDC to prevent the growth of yeast 
in wine on 21.10.1988 and a further petition for the inhibition of yeasts in alcoholfree wine and 
low alcohol wine by the addition of up to 200 mg/1 of DMDC, provided the initial yeast counts 
are reduced to less than 500 viable cells after an initial filtration or pasteurisation. 
DMDC was also evaluated by JECFA in 1990 as set out in the 37
t
n Report. No ADI was 
allocated because the compound disappears after hydrolysis in aqueous media and cannot 
therefore be determined by analysis. It was however judged acceptable as cold sterilising agent 
up to a level of addition of 250 mg/1. 
It has been marketed in Germany since 1979 as a processing aid not requiring registration as a 
food additive. However, following a request for inclusion as a preservative in the German 
Food Additive Regulations and a recommendation of the Senate Commission on food 
additives and ingredients of the German Research Association (DFG) on its acceptability for 
this purpose up to a level of addition of 250 mg/1, DMDC was included in the German Food 
Additive legislation in June 1990. 
In December 1993 the French authorities submitted a Report of the Section on Food and 
Nutrition of the Conseil Supérieur d'Hygiène Publique de France which questioned the SCF 
evaluation of acceptability because in their view some unresolved safety questions still 
remained. 
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Introduction 
DMDC, by virtue of its broad spectrum of antimicrobial activity, has the advantage when used 
as cold sterilant of fruit juice based beverages of leaving no residues because of its virtually 
complete hydrolysis in aqueous media to methyl alcohol and CO2. It does however form 
minute amounts of reaction products such as carbomethoxylation products of naturally 
occurring amines, amino acids, sugars and fruit acids (lactic acid, citric acid, ascorbic acid). In 
the presence of ammonia and NH4
+ ions very small amounts (less than 25 μg/l) of 
methylcarbamate are formed. Other reaction products identified were dimethylcarbonate and 
ethylmethylcarbonate from reaction with methyl and ethyl alcohol. No ethylcarbamate has 
been shown to arise by transesterification. 
The quantities of reaction products found after treatment with 250 mg/1 of DMDC were: 
dimethylcarbonate less than 0.5 mg/1 
Total carbomethoxyderivatives 1.7-5 mg/1 
methylcarbamate less than 25 pg/1 
methanol 120 mg/1 
C02 160 mg/1 
Non-gaseous soft drinks and fruit juice based beverages are treated with 125-250 mg/1. 
Gaseous beverages with sugar require 60-190 mg/1. The process is only efficacious if the inital 
microbial count is less than 300 viable organisms/1 hence prior treatment to reduce initial 
counts to this level is necessary. The treatment causes no change in colour, odour or taste of 
the beverage. 
Comments of the French authorities 
The issues raised by the French authorities highlight certain aspects of the DMDC database 
considered by the SCF which they perceive to be incomplete. Their comments were as 
follows: 
1. Because of the virtually complete disappearance of DMDC in the treated beverage it is not 
possible to control analytically the level of addition except through determination of the 
total methyl alcohol present which includes the naturally present material. As the natural 
background of methyl alcohol varies with the type of fruit juice used an accurate analytical 
control of the treatment applied is not possible. 
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2. There is no disagreement with the SCF view that even with a consumption of 2 1 
beverage/day for a lifetime the intake of reaction products would be very small. 
3. Only 2 types of fruit beverages have been tested namely orange juice and redcurrant juice. 
As other fruit juices may have different compositions regarding amines, amino acids, sugars 
and fruit acids it is felt that generalisation of the toxicity assessment with respect to the 
reaction products to all fruit juices is not justified. Furthermore, no carbomethoxy 
derivatives of sugars and fruit acids have been identified and toxicologically examined. A 
total of only 11 carbomethoxy derivatives of amino acids have been examined 
toxicologically excluding histidine and serine, which are also present in fruit juices. The 
assumption of linearity of the curve relating the formation of derivatives to the 
concentration of reactants has only been validated for lactic acid. Apparently this curve is 
not linear for ascorbic acid. The relationship between reaction products formed and 
different concentrations of DMDC has not been investigated. 
4. Methylcarbamate was shown to be a hepatocarcinogen in the F 344 rat in an NTP study, 
the NOEL was established at 100 mg/kg b.w. However, methylcarbamate is not 
carcinogenic in the Wistar rat nor in 2 different mouse strains. It is also not genotoxic in 
several in vitro and in vivo genotoxicity tests with different endpoints. In the view of the 
FDA the difference between the exposure to methylcarbamate arising from a consumption 
of about 20 μg/l beverage and the NOEL of 100 mg/kg b.w. in the lifespan study in the rat 
is of the order of several magnitudes. In addition the calculated upper bound lifetime risk of 
cancer from ingestion of methylcarbamate is about 1 in 42 million. The FDA therefore 
concluded that there is a reasonable certainty of no harm arising from consumption of 
DMDC-treated beverages. The SCF has concurred with this view but the French authorities 
doubted the validity of the risk calculation and would prefer to see a comparative 
metabolism study carried out for DMDC in the F344 and the Wistar rat to explain the 
different carcinogenic response. 
5. In the studies carried out with overtreated orange juice and wine (4000 mg/1 DMDC) no 
estimation of total carbomethoxy derivatives was carried out. Hence their negative outcome 
cannot be related quantitatively to the amounts found at the technologically permitted 
treatment level making the significance of the negative results doubtful. 
6. The SCF did not pronounce in its report on the question of technological need. This is 
challenged by the French authorities because they claim to have an industrially effective 
process using aseptic conditioning of beverages. However, it is admitted that this process 
needs special equipment and is more expensive but it obviates the appearance of any 
reaction products with possible toxic potential and would therefore be a suitable alternative. 
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Conclusions of the Committee 
The quantities of reaction products identified are very small and though not every theoretically 
possible carbomethoxy derivative has been investigated, their toxicological innocuity has been 
demonstrated in feeding studies on overtreated orange juice. Orange juice was selected as a 
model beverage because it has been shown to be the most representative fruit juice as regards 
the natural variability in concentration and occurrence of amino acids, sugars and fruit acids 
found in different fruit juices. Moreover DMDC is not used on pure 100% fruit juice or on 
50% nectars but on beverages containing between 6 and 20% fruit juice only. The amounts of 
possible reaction products likely to be formed in beverages treated with DMDC at a level of 
250 mg/1 are therefore about 80-fold lower than were presumably present in the 16-fold 
overtreated fruit juice. 
The assumption that the carcinogenic response to methylcarbamate in the F344 rat is an 
epigenetic phenomenon is supported by the absence of any genotoxic potential. Moreover, 
methylcarbamate is not carcinogenic in either the Wistar rat or in two different strains of 
mouse. For this reason the establishment of a NOEL and a safety factor approach is 
appropriate. Further metabolic investigations would not affect the conclusions based on the 
safety factor approach. In making a risk assessment, the difference of several orders of 
magnitude between the NOEL in the long-term rat study and the residues from the proposed 
treatment level offers a reasonable assurance of safety for the consumer from exposure to the 
methylcarbamate formed in treated beverages. The existence of an alternative technology not 
resulting in any treatment residues is a welcome development but does not offer any scientific 
reasons to challenge the acceptability of DMDC treatment, the safety of which has been 
reasonably demonstrated. 
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Terms of reference 
On the basis of the information provided by the Member States, to advise the Commission on 
the public health implications of the presence of phthalates in infant formulae. 
Background 
The Commission was notified by the UK of the results of an investigation into the 
contamination of infant formulae with various phthalates and of related findings in the fatty 
food groups of total diet samples collected as part of the routine UK diet surveys (1,2). 
Germany and Austria also provided results of investigations into the presence of phthalates in 
certain food products on their respective markets, but they did not include infant formulae. 
The current situation concerning TDIs established by the Committee for phthalates is 
as follows: 
Phthalate 
Di (2-ethylhexyl) (DEHP) 
Butylbenzyl (BBP) 
Dibutlybenzyl (DBP) 
Dicyclohexyl (DCHP) 
Diethyl 
Others used in Food contact materials 
TDI 
mg/kg b.w. 
0.05 
0.1 
0.05 
0.1 
0.2 
0.05 
Status of TDI 
Full 
Temporary 
Temporary 
Temporary 
Temporary 
Temporary Group 
restriction for migration 
Discussion 
Phthalates are industrial chemicals produced in very large tonnages world wide and are known 
to be environmental contaminants with a high solubility in fat. Their presence in infant 
formulae and other fat containing food products is therefore not unexpected. The UK data 
cover infant formulae, fresh cows milk, milk products, meat, poultry, fish and eggs. The 
German data cover baby foods for children already weaned while the Austrian data cover a 
wide variety of food products with more detailed data on milk and its products. No data on 
phthalates in human breast milk are available to the Committee but their presence in this 
medium could be expected because of its high fat content and the occurrence in it of other fat 
soluble environmental contaminants. 
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In the various infant formulae the levels of total and individual phthalates analysed were 
comparable. The UK figures show that the estimated intakes of individual phthalates were all 
below the relevant TDI or temporary TDIs set by the Committee (3,4). Given the uncertainties 
about which unknown phthalates are included in the measurements of total phthalates and the 
incomplete knowledge concerning the toxicological profile of such mixtures, the Committee 
considers that it is inappropriate to compare the level of total phthalates as measured with the 
SCF group restriction for migration from food contact materials equivalent to 0.05 mg/kg 
bw/day. 
Earlier reproduction and teratology studies on several phthalates have already revealed effects 
on the testis and on embryonic development, but only at very high doses, and these studies 
were included when the Committee established its TDIs. 
Since then new evidence on the reproductive effects of phthalates has been published (5,6). In 
the Sharpe et al. study (5) on rats, only a single dose level of butylbenzyl phthalate (BBP) was 
tested, estimated to range from 0.1 to 0.4 mg/kg bw/day, via the mothers' drinking water 
throughout pregnancy and lactation. It showed minor effects on testis weight and sperm 
production. These preliminary findings suggest that reproduction could be affected by BBP at 
low doses from exposure during prenatal and early postnatal life, but require confirmation. In 
a study by the National Toxicology Program (NTP) dibutyl phthalate (DBP) was administered 
in the diet to rats during pregnancy and lactation (6). The male offspring continued to receive 
DBP for 17 weeks after weaning also via the diet. The study showed neither testicular lesions 
nor reduction of testis weight at a dose level of 279 mg/kg b.w. These effects were observed 
at higher dose levels. 
Conclusions 
At the present time, the Committee sees no reasons to change its current TDI or its current 
temporary TDIs. 
It notes that the data provided by the UK for individual phthalates was based on only recently 
developed methodology. 
The Committee concludes that the estimated intakes of individual phthalates are all well below 
their respective TDI or temporary TDI. 
From the UK analytical data the highest estimated intake of BBP was 0.009 mg/kg b.w./day, 
which is well below the temporary TDI of 0.1 mg/kg b.w. It is also ten times below the level 
where effects were reported in the Sharpe et al. study (5). The Committee considers it 
important that the findings of Sharpe et al. are followed up, but in the meantime it is of the 
opinion that the levels of BBP found in infant formulae are unlikely to pose a risk to health. 
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For DBP the highest estimated intake was 0.014 mg/kg b.w./day which is below the temporary 
TDI of 0.05 mg/kg b.w. The recent NTP study (6) on DBP does not provide any cogent 
reason to change the temporary TDI. It is therefore the opinion of the Committee that the 
levels of DBP found in infant formulae do not pose any risk to health. 
As concerns total phthalates, the Committee considers it inappropriate to compare the level of 
total phthalates as measured with the SCF group restriction for migration from food contact 
materials equivalent to 0.05 mg/kg b.w./day. 
For the risk assessment of phthalates, the Committee stresses the need for further data on the 
occurrence of phthalates in food in general and for improvements in analytical methodology. 
Moreover, because it is known that phthalates are ubiquitous in the environment, the 
Committee is of the opinion that consideration should be given to the environmental aspects 
by the appropriate bodies. 
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Terms of reference 
To advise the Commission on the calculation of the vitamin E content of infant formulae and 
follow-on formulae. 
Background 
Directive 91/3 21/EEC
1 on infant formulae and follow-on formulae specifies that these 
products shall contain a minimum vitamin E content of 0.5 mg TE
2/g of polyunsaturated fatty 
acids (PUFAs) expressed as linoleic acid (Annex 1,6 and Annex 11,6). 
The UK seeks guidance from the European Commission on how this recommendation should 
be interpreted, particularly because of the more extensive use of PUF A in infant formulae and 
follow-on formulae. The European Commission has in turn asked for guidance from the 
Scientific Committee for Food on this matter. 
Discussion 
It is necessary first to consider if the proposed reference E : PUF A ratio, i.e. the ratio of the 
amount of vitamin E (mg of d-α tochopherol) to the amount of PUF A in grams, of 0.5 is safe 
and adequate. From an evaluation of the results of human and animal experiments which diets 
rich in linoleic acid it was proposed that a ratio of 0.6 is necessary to prevent vitamin E 
depletion (Harris & Embree, 1963). In different conditions, the minimum symptom-free ratio 
was found between 0.4 and 0.8; these differences include the particular deficiency sypmtom 
under examination as well as time of depletion and effects of minerals and other nutrients in 
the experimental diets (Muggii, 1989). Thus, even if a value of 0.6 may safely be assumed, the 
current 0.5 value could remain the reference base of calculation. 
PUFAs increase the requirement for vitamin E. Highly unsaturated molecules are 
preferentially peroxized. Holman found that as the number of double bonds increase from 1 to 
6, the relative maximum rate of auto-oxidation of individual pure fatty acid methyl esters in 
1 Directive 91/321/EEC on infant formulae and follow-on formulae, O.J. L-175/35, 4.7.91 
2 TE = Tocopherol Equivalent 
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vitro at 37°C were in the ratios 0.025 : 1 : 2 : 4 : 6 : 8 (Holman 1954). The results of in vivo 
studies have given however slightly different results. By feeding a variety of fats which differ 
in composition with respect to PUF As to young, tocopherol-deficient rats and recording the 
time onset of creatinuria, a symptom of muscle cell membrane damage, Witting et Horwitt 
have estimated that the rates of peroxidation of mono-, di-, tri-, tetra-, penta-, and hexaenoic 
fatty acids in terms of relative tocopherol requirements was 0.3, 2, 3, 4, 5, and 6, respectively 
(Horwitt, 1962; Witting & Horwitt, 1964). Thus, the relative vitamin E requirement, as 
determined in vivo, can be converted to absolute figures (table below). 
TABLE 
ESTIMATED MINIMUM REQUIREMENTS OF d - α- TOCOPHEROL ACCORDING TO THE 
DEGREE OF UNSATURATIQN OF PUFA PRESENT IN INFANT FORMULAE. 
Fatty acids 
Linoleic 
α - linolenic 
Arachidonic 
Eicosapentaenoic 
Docosahexaenoic 
Double bounds 
2 
3 
4 
5 
6 
Vitamin Ei
1) 
requirements 
(mg/g fatty acid) 
0.5 
0.75 
1 
1.25 
1.50 
(1) d_ α . tocopherol 
Conclusion 
The Committee therefore recommends that the vitamin E content for infant formulae and 
follow-on formulae shall be calculated on the basis of the recommended vitamin E content, 
and taking into account the number of unsaturated bonds given by the PUFA content of the 
formulae, as it is illustrated by the representative fatty acids in the above table. In no case 
shall the content be less than 0.5 mg TE/100 kcal. 
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Introduction 
Whenever changes are made to the way in which a food is put on the market, produced 
or processed or non-traditional ingredients are used, the implications for consumer 
safety and nutritional value will require consideration. Information will be needed on any 
issue relating to both these aspects. At present, the issue of food safety in relation to 
novel foods is under consideration worldwide. The World Health Organization (WHO), 
the Organization for Economic Cooperation and Development (OECD), and other 
national and international bodies have addressed both general and specific aspects 
relevant to the wholesomeness of novel foods. A number of reports outline the 
philosophies and the developments in this field (see references). 
As part of the development of the EU Regulation on Novel Foods and Novel Food 
Ingredients the European Commission has asked the Scientific Committee for Food 
(SCF) to develop recommendations concerning the scientific aspects of 
I. the information necessary to support an application for placing on the market of 
novel foods and novel food ingredients, 
II. the presentation of such information, 
III. the preparation of the initial assessment reports. 
This report covers task I. 
Categories of novel foods and novel food 
ingredients identified in the EU regulation 
According to the Common Position (EU 25/95) of the Council of October 23, 1995 
(95/C 320/01)
1 the EU regulation will apply to the placing on the market of foods or 
food ingredients which have not hitherto been used for human consumption to a 
significant degree within the EU and which fall under the following categories: 
(a) Foods and food ingredients containing or consisting of genetically modified 
organisms within the meaning of Directive 90/220/EEC
2; 
'OJC320of30.il.1995, p. 1 
2OJL117of8.5.1990, p. 15 
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(b) Foods and food ingredients produced from, but not containing, genetically 
modified organisms; 
(c) Foods and food ingredients with a new or intentionally modified primary 
molecular structure; 
(d) Foods and food ingredients consisting of or isolated from microorganisms, fungi 
or algae; 
(e) Foods and food ingredients consisting of or isolated from plants and food 
ingredients isolated from animals, except for foods and food ingredients obtained 
by traditional propagating and breeding practices and which have a history of safe 
use; 
(f) Foods and food ingredients to which has been applied a production process not 
currently used, where that process gives rise to significant changes in the 
composition or structure of the foods or food ingredients which affect their 
nutritional value, metabolism or the level of undesirable substances. 
The regulation does not apply to: food additives falling within the scope of Council 
Directive 89/107/EEC
3; flavourings for use in foodstuffs falling within the scope of 
Council Directive 88/388/EEC
4; or extraction solvents used in the production of 
foodstuffs falling within the scope of Council Directive 88/344/EEC
5. 
Key issues for the assessment of novel 
foods and novel food ingredients (NF) 
3.1 General considerations 
Foods are usually complex mixtures of macro- and microconstituents which provide 
energy and nutrients and contribute to the well-being of humans. They have traditionally 
been regarded as natural, beneficial and necessary products whose safety and nutritional 
value need not be questioned. Regulatory approaches to food safety have reflected this 
attitude and have focused on food additives, processing aids and contaminants of natural 
or industrial origin. Thus, foods have not hitherto been systematically subjected to 
nutritional or toxicological evaluation, except in rare cases, where acute toxic effects 
have been reported in humans (e.g. solanine, cyanogenic glycosides) or in those cases, 
3OJL40of 11.2.1989, p. 27 
4OJL184of 15.7.1988, p. 61 
5 OJL157 of 24.6.1988, p. 28 
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where animal studies or human experiences have suggested adverse effects from raw 
food materials (e.g. raw soya flour). This is not to imply that nutritional evaluation of 
individual foods and of whole diets has not been performed, but that such nutritional 
evaluations have not been used as a basis for a safety assessment of individual foods. On 
the other hand, food additives are not permitted in food unless they have been subjected 
to exhaustive toxicological evaluation. 
Various foods are known to contain toxic compounds, including mutagens and 
carcinogens. Some chronic diseases in humans have a dietary element in their etiology. 
Although it is agreed that some adverse effects of the diet on health are related to the 
pattern of nutrient intake, the exact mechanisms involved are not known. It is possible 
that some ill health is due to chronic exposure to constituents of traditional foods. Until 
recently little attention has been given to this aspect or to the possible role of modifiers 
of toxic effects (e.g. anticarcinogens) naturally present in foods. 
The assessment of the wholesomeness of foods including novel foods and novel food 
ingredients (NF) presents a number of scientific challenges. Conventional toxicological 
evaluation methods cannot be applied to foods, because foods present particular 
difficulties not encountered with the testing of food additives and contaminants in vivo 
and in vitro. For example, the amount of food to be incorporated in the diet for animal 
feeding studies without perturbing its nutritional balance makes the use of conventional 
safety factors inappropriate for risk assessment and management for any product 
intended for use as a food or a major food ingredient. Furthermore, traditional metabolic 
and pharmacokinetic studies are not directly applicable to complex chemical mixtures 
like foods. The use of mutagenicity and other in vitro tests for foods requires special 
techniques and cautious interpretation of the results. 
Therefore, alternative approaches for the testing and assessment of the wholesomeness 
of foods and major food ingredients are needed. The ultimate strategy for combined 
nutritional- toxicological testing will extend from initial tests in vitro and in vivo studies 
in animal models to studies in humans if needed. 
3.2 Genetically Modified Organisms (GMO) 
Directives 90/219/EEC
6 and 90/220/EEC as amended by directive 94/15/EU set out the 
information requirements for the safety of the contained use of genetically modified 
microorganisms (GMM) and the safety of the deliberate release of genetically modified 
organisms (GMO), respectively. The requirements in these directives are also relevant to 
GMO covered by the EU Regulation on Novel Foods and Novel Food Ingredients and 
6OJL117of8.5.1990,p. 1 
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fulfill basic information requirements needed for the safety assessment of NF. The 
present recommendations specifically focus on those aspects relevant to human food 
safetv issues. 
3.3 Substantial equivalence 
The concept of "substantial equivalence" has been introduced by WHO and OECD with 
particular reference to foods produced by modern biotechnology. In the terminology of 
the OECD, the concept of substantial equivalence embodies the idea that existing 
organisms used as foods or as food sources, can serve as a basis for comparison when 
assessing the safety of human consumption of a food or food component that has been 
modified or is new. If a new food or food component is found to be substantially 
equivalent to an existing food or food component, it can be treated in the same manner 
with respect to safety, keeping in mind that establishment of substantial equivalence is 
not a safety or nutritional assessment in itself, but an approach to compare a potential 
new food with its conventional counterpart. 
The application of the principle of substantial equivalence can be extended to the 
evaluation of foods from novel sources and processes. Substantially equivalent NF are 
thus comparable, in terms of safety, to their conventional counterpart. Substantial 
equivalence may be established either for the whole food or food component including 
the introduced "new" change, or it might be established for the food or food component 
except for the specific "new" change introduced. If a NF has not been found to be 
substantially equivalent to an existing food or food component, this does not imply that 
it is unsafe. It just indicates that such a NF should be evaluated on the basis of its unique 
composition and properties. 
The establishment of substantial equivalence is an analytical exercise in the assessment of 
the relative wholesomeness of a NF compared to an existing food or food component. It 
contains a dynamic element, as the continuing modification of a food requires that the 
basis of comparison will evolve in a way that the most recent NF is compared with an 
appropriate former NF and not necessarily with the most traditional counterpart. 
The comparison may be a simple task or be very lengthy depending upon experience 
with and the nature of the NF under consideration. The technical approach to 
establishing substantial equivalence will differ between whole animals, plants, 
microorganims, chemical food ingredients and novel processes and is addressed in more 
detail under the different classes later in these recommendations. 
38 Reports of the Scientific Committee for Food (Thirty-ninth Series) 7 JUNE 1996 NOVEL FOODS AND NOVEL FOOD INGREDIENTS 
3.4 Compositional analysis 
Analytical studies of the composition of the NF are of crucial importance not only for 
the establishment of substantial equivalence but also as a prerequisite for nutritional and 
toxicological assessments. Methods applied have to be standardized and validated to 
ensure quality and consistency of the data. The analyses and data presented should be 
based upon sound scientific principles and should be tailored to the nature of the NF. 
Investigations should focus especially on the determination of the content of critical 
nutrients (both macro- and micronutrients) and any critical toxicants and anti-nutritional 
factors which might be either inherently present or process derived. 
3.5 Intake 
The consumption pattern may show a major change when a NF is included in the diet 
and thus affects human nutritional status. As it may not be possible to predict such 
events, a surveillance programme should accompany the marketing of a NF. Such a 
programme should encompass information on changes in the conditions for processing 
and preparation as well as effects of possible replacement of other foods or food 
components of dietary importance. If surveillance reveals changes in those factors which 
raise concerns regarding wholesomeness, a reappraisal of the acceptability of the NF 
would be required. 
3.6 Nutritional considerations affecting toxicological testing in animals 
In the overall evaluation it is of crucial importance to interprete carefully any adverse 
effects seen in animal studies and to distinguish between toxic effects and those due to 
nutritional imbalance in the experimental diet. Thus, nutritional and toxicological aspects 
have to be closely integrated in the assessment of NF. Thorough knowledge of the 
nutritional properties of the NF (e.g. energy value, protein content, and bioavailability of 
micronutrients) is needed as a prerequisite of the toxicological testing programme. In 
designing animal feeding studies, the maximum level of dietary incorporation achievable 
without causing nutritional imbalance should be the highest dose level, while the lowest 
dose level should be comparable to its anticipated role in the human diet. 
If the predicted usage levels and consumer intakes are likely to be high, the application 
of the traditionally calculated safety factors employed in safety assessment may create 
difficulties in designing conventional animal feeding studies with adequate dietary 
incorporation levels to ensure clearance for use in humans at the anticipated 
consumption levels. To compensate for the inability of employing reasonably adequate 
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safety factors any subchronic or chronic animal feeding studies require supplementation 
by absorption and metabolism studies in animals and eventually in humans. 
A holistic scientific interpretation of the overall wholesomeness assessment data on a 
case-by-case basis can provide the acceptable justification for the use of safety factors 
for NF lower than those traditionally used in safety assessment. 
3.7 Toxicological requirements 
In principle, the toxicological requirements for NF need to be considered on a case-by-
case basis. In establishing the need for the provision of toxicological data three scenarios 
may be considered: 
(1) Substantial equivalence can be established to an accepted traditional food or food 
ingredient, in which case no further testing is needed. 
(2) Substantial equivalence can be established except for a single or few specific traits 
of the NF, in which case any further assessment of safety should focus specifically 
on these traits. 
(3) Neither partial nor total substantial equivalence can be established; in this case, the 
wholesomeness of the whole novel food or macronutrient has to be assessed using 
an appropriate combined nutritional - toxicological approach. 
If substantial equivalence to a traditional counterpart cannot be established the 
wholesomeness assessment has to take into account not only knowledge of the identity, 
chemical structure and physico-chemical properties of the NF but also aspects such as 
source, composition, potential intake based on the proposed use in the general diet, the 
potential exposure of particularly vulnerable population groups, and the likely effects of 
processing. The greater the predicted dietary exposure the more extensive the required 
toxicological testing programme will have to be. 
3.8 Implications of NF to human nutrition 
The overall assessment must consider nutritional implications both at expected 
customary (normal) intakes and at maximum levels of consumption. This evaluation will 
be guided by a thorough appraisal of relevant literature, compositional analyses, 
comparisons to consider substantial equivalence, and, if needed, data from investigations 
in animal models. If a NF is expected to have an important role in the diet then 
appropriate human nutritional assessment data are needed. Attention should be paid to 
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the particular physiological characteristics and metabolic requirements of groups such as 
infants, children, pregnant and lactating women, the elderly, and those with chronic 
diseases (e.g. diabetes mellitus and malabsorption). 
o 
Information will be needed on long term as well as on short term effects of eating the 
NF. The appropriate information should be derived by combined nutritional and safety 
post-market surveillance, but additionally consideration should be given to addressing 
these effects by specific concerns about nutritional quality (e.g. the long term effect of 
fat replacers on the metabolism of fat soluble vitamins). 
3.9 Novel microorganisms used in food 
Microorganisms may be used as producers of foods, food ingredients or food additives. 
Many have a long tradition of safe use in food fermentations. They may be killed in the 
fermented product or consumed alive with it. 
By definition, microorganisms with no traditional use in food production in Europe 
cannot have a substantially equivalent counterpart in Europe and will therefore need to 
be assessed. Relevant criteria are: containment (e.g. limited to fermentor, remaining alive 
in food or killed during processing); potential for colonisation of the mammalian gut; 
potential for toxigenicity as well as pathogenicity in mammals; and whether genetic 
engineering was applied or not. If genetic modification is employed, the considerations 
on potential transfer of genetic material from GMM as described in 5.VII become 
relevant. 
The safety assessment of a GMM should consider the origin of the newly introduced 
material, e.g. vectors, regulatory elements, foreign genes including target and marker 
genes. Two cases have to be considered: 
• the homologous system (self cloning), where all genetic elements involved are 
derived from strains within the same taxonomie species, 
• the heterologous system, where the donor organism of the genetic elements 
belongs to a taxonomie species other than that of the recipient. 
Generally, the segregational and horizontal stability of the constructs are of interest. For 
self-cloned organisms the concept of substantial equivalence might be applicable in most 
cases. In heterologous systems both the safety of the gene product in relation to its 
effects on the food and the effect of the new trait on the properties of the microorganism 
in the food and, after ingestion, in the gut need to be assessed. The implication of 
horizontal gene transfer in the gut should be analyzed and evaluated. 
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3.10 Allergenic potential 
The potential occurrence of allergic reactions to novel proteins or other constituents of 
NF should be explored. As a general principle of assessment, the immunological 
reactivity of individuals who react to the traditional food counterpart should be tested in 
vitro and in vivo against the NF. The latter approach may raise ethical issues which must 
be taken into account. If the novel protein is expressed by genes derived from a source 
known to be associated with food allergy, sera of people with confirmed allergies to that 
source can be subjected to specific immunological tests, e.g. Western Blotting or 
radioallergosorbent test (RAST). If in vitro tests are negative, in vivo skin prick tests or 
clinically supervised double blind placebo controlled challenges in these people may be 
performed. All studies should comply with relevant elements and ethical principles of 
guidelines on Good Clinical Practice and Good Laboratory Practice. 
A number of factors can serve as indicators of the potential allergenicity of novel 
proteins, such as sequence epitope homology with known allergens, heat stability, 
sensitivity to pH, digestibility by gastrointestinal proteases, detectable amounts in 
plasma, and molecular weight. Additional evidence might emerge from pre-marketing 
human results and reports of workers' sensitizations. 
New approaches are needed to assess the potential allergenicity of NF in humans. In the 
present state of knowledge, the allergenicity of a novel food from a GM source should 
include consideration of the allergenic potential of the donor and of the recipient 
organism. 
3.11 Assessment of marker genes. 
Marker genes are used as "tags" to identify and to select those cells of plants or 
microorganisms which have been transformed successfully by genetic modification. 
Normally they are not supposed to play a role of their own in the final product or NF. 
The marker genes, presently used most frequently in plants, are those conferring 
resistance to antibiotics or increased tolerance to herbicides. Others confer heavy metal 
tolerance or phenotypic and biochemical selection. The requirements for evaluating the 
safety of marker genes are basically similar to those applicable to the safety evaluation of 
any other foreign genes. 
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The assessment in plants needs to consider: 
• the marker gene itself and the product it encodes; 
• the methods for analyzing and quantifying the marker gene and its expression 
products in the food, 
• the potential toxicological and/or nutritional effects related to the function of the 
marker gene, 
• the potential for horizontal gene transfer to gut microorganisms. 
The use of marker genes in microorganisms, especially those genes conferring antibiotic 
resistance, has to be assessed in relation to the host organism, the biological containment 
established by the genetic construct, the possibility of colonization of the human gut by 
these GMO, and the relationship between the efficacy of antimicrobials and the acquired 
resistance. 
It can be foreseen that a list of approved marker genes can be developed based upon an 
evaluation of their primary effects on the host organism. Their secondary effects on the 
host will depend, among other factors on the insertion site in the host DNA and will 
need an assessment on a case-by-case basis, although there is no reason to suppose that 
the potential for secondary effects is greater for marker genes than for any other inserted 
genes. 
Scientific classification of novel foods 
for the assessment of whole-someness 
Foods and food ingredients which fall within the scope of the EU Regulation on Novel 
Foods and Food Ingredients are very diverse (see Section 2). To facilitate safety and 
nutritional evaluation, six classes of NF have been identified. These differ in complexity 
and in the issues that need to be addressed. 
For the purpose of these recommendations, the term "plants" covers also seaweed. The 
term "animals" includes fish and shellfish, and the term "microorganism" encompasses 
bacteria, fungi (including yeasts), and micro-algae (viruses and plasmids are outside the 
scope of these guidelines). 
Class 1 : Pure chemicals or simple mixtures from non-GM sources 
This class comprises foods and food components that are single chemically defined 
substances or mixtures of these which are not obtained from plants, animals or 
microorganisms that have been genetically modified. Two sub classes can be identified: 
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1.1 the source of the NF has a history of food use in the EU. 
1.2 the source of the NF has no history of food use in the EU. 
Class 2: Complex NF from non-GM sources 
This class comprises complex NF which are or are derived from sources which have not 
been genetically modified. Intact plants, animals and microorganisms used as foods as 
well as food components (e.g. complex carbohydrates, fats, proteins or those substances 
collectively described as dietary fibre) are included. Two sub classes can be identified: 
2.1 the source of the NF has a history of food use in the EU. 
2.2 the source of the NF has no history of food use in the EU. 
Class 3: GM plants and their products 
GM plants can be consumed directly as unprocessed foods or after having been 
processed into foods and food ingredients including pure chemicals. This class of NF 
includes all such foods and food ingredients. Two sub classes can be identified: 
3.1 the host plant used for the genetic modification has a history of use as food or as a 
source of food in the EU under comparable conditions of preparation and intake, 
3.2 the host plant used for the genetic modification has no history of use as food or as 
a source of food in the EU under comparable conditions of preparation and intake. 
Class 4: GM animals and their products 
GM animals can be consumed directly as unprocessed foods or after having been 
processed into foods and food ingredients including pure chemicals. Products directly 
produced by GM animals (e.g. eggs, milk) can be consumed either processed or 
unprocessed. This class of NF includes all such foods and food ingredients. Two sub 
classes can be identified: 
4.1 the host animal used for the genetic modification has a history of use as food or as 
a source of food in the EU under comparable conditions of preparation and intake. 
4.2 the host animal used for the genetic modification has no history of use as food or 
as a source of food in the EU under comparable conditions of preparation and 
intake. 
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Class 5: GM microorganisms and their products 
Living GM microorganisms may be used in food production or in the production of food 
ingredients. This class includes all NF which are, or are produced using, GM 
microorganisms whether or not there are any living cells in the NF as consumed: Two 
sub classes can be identified: 
5.1 the host microorganism used for the genetic modification has a history of use as 
food or as a source of food in the EU under comparable conditions of preparation 
and intake. 
5.2 the host microorganism used for the genetic modification has no history of use as 
food or as a source of food in the EU under comparable conditions of preparation 
and intake. 
Class 6: Foods produced using a novel process 
This class comprises foods and food ingredients which have been subjected to a process 
not currently used in food production. Novel processes for food production may 
encompass for example new types of heat processing, non-thermal preservation 
methods, new processes to chill or freeze products, to dehydrate products, and the 
application of new processes catalyzed by enzymes. According to the scope of the EU 
regulation, the resulting product is only considered to be a NF, if the process results in 
changes in the chemical composition or structure of the food or food ingredient, which 
affect its nutritional value, metabolism or level of undesirable substances. 
The association between the described classes and the categorization in the EU 
Regulation on Novel Foods and Novel Food Ingredients is outlined in Table I. 
5. Identification of essential information 
for assessment of wholesomeness 
In this section structured schemes are provided to identify the types of information that 
are likely to be required to establish the safety of particular classes of NF. It is 
recognized that no formalistic approach can cover adequately all NF, and these schemes 
are therefore provided for guidance only. If other information is available or relevant for 
the assessment, it should be submitted. However, if it is proposed to omit certain 
information from a dossier requested in any of the schemes, the scientific justification for 
this should be given. The results of any investigations relevant to safety assessment 
which have been carried out must be reported. 
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In the assessment of NF the focus is the novelty per se. Chemical or microbiological 
contaminants of NF not specifically related to the novelty are not addressed in these 
recommendations. Similarly, the presence of microbial toxins and microbial or viral 
infective agents is not considered unless this is a consequence of the novelty. 
The identification of essential information for assessment is guided by the division into 
six classes described in chapter 4. After allocating a NF to a class or subclass, the 
attached Table II can be used to determine which of the structured schemes I-XIII 
should be consulted to provide the information required to support its safety and 
nutritional evaluation. 
In the following, the information requested in each particular structured scheme is 
specified in more detail: 
I. Specification of the NF 
Specification of the origin and the composition of the NF is needed to ensure the identity 
between the product tested/evaluated and the product to be marketed. In the design of 
the specification, parameters most relevant to characterize the product from a safety and 
nutritional point of view should be considered. 
Such parameters include species and taxon, as well as chemical composition relating 
particularly to nutritional properties and possible antinutritional/toxicological concerns. 
Taxonomie identity should be established according to referenced and internationally 
accepted principles and deviation from such principles should be explained. 
Information on the availability of specified reference material should be submitted. 
II. Effect of the production process applied to the NF 
In principle, this scheme applies to all NF which have been processed during production. 
The description of the technical details has to be sufficiently detailed (i) to permit a 
distinction between novel and existing processes, and (ii) to predict whether the 
potential of the process to introduce physical, chemical and/or biological changes in the 
food might have an impact on essential nutritional, toxicological and microbiological 
parameters of the final product. 
The assessment of new technologies needs to address any organic and inorganic residues 
or contaminants derived from apparatus and equipments or from chemical, physical or 
biological aids used in the novel process. Critical aspects of the production process in 
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relation to NF are those, which ensure that the final products of the described process 
comply with the specifications given under scheme I. 
As regards hygienic parameters, these are not included in the assessment of NFs but are 
covered by Directive 93/43/EEC
7. 
The assessment will focus on the food product resulting from the novel process on a 
case-by-case basis. The ultimate aim of assessment will be the evalution of the process in 
a wider sense without the need for actually testing and assessing each conceivable 
food/process combination. This implies a broader strategy in which representatives of 
relevant food classes, processed by the novel food process, should be compared either to 
untreated counterparts or to counterparts which have been processed in a related 
traditional manner. 
ΙΠ. History of the organism used as the source of the NF 
The novelty of food plants, food animals or food microorganisms in relation to these 
guidelines is defined by their novelty in the European food supply. If species/taxons of 
plants, animals or microorganisms have had no generally recognised use in the diet of 
any of the EU countries according to national dietary records, the species/taxon is 
considered new, and a full description is needed to assess its future role in the European 
food supply. This should include information on the past and present use of the plant, 
animal or microorganism and its products in the food supply in other parts of the world. 
Such information should also include: 
• past and present methods to obtain raw materials and food, e.g. by raising, 
harvesting, slaughtering, and capture, 
• procedures for fermentation and preparation, 
• description of transport and storage conditions, and 
• its traditional role in the diet at locations outside the EU. 
IV. Effect of the genetic modification on the properties of the host organism 
The information gathered through this scheme focuses on the effects of the genetic 
modification on the properties of the GMO compared to the host organism. It 
differentiates between intendend and unintended effects. In the latter case, special 
attention should be given to any nutritional, toxicological, and microbiological impact on 
the foods. 
7OJL175of 19.7.1993, p. 1 
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GM plants. The principles for evaluating GM plants and their products are similar to 
those valid for non-GM plants and their products. The safety evaluation of a GM plant 
may be a simpler task than the evaluation of a novel non GM plant, if the nonmodified 
organism is a traditional food plant and the alteration has occurred by means of a 
precisely defined process of genetic modification. In this case, the safety assessment can 
focus on the results of the genetic modification. 
Where the genetic modification results in a new phenotype, the compositional 
consequences of this modification should be defined and tested. If, for example, a 
genetically modified plant is so designed as to express a naturally occurring insecticide, 
encoded by a gene derived from another organism, and has therefore become resistant to 
certain insect pests, then the toxicological profile of the introduced insecticidal 
component needs to be determined. The safety of this modification of the chemical 
composition can be evaluated by standard toxicological procedures; it should include an 
assessment of the potential allergenicity. In addition, secondary effects (positional 
effects) have to be taken into consideration. These effects of the insertional event, e. g. 
the insertional mutation itself or a genomic rearrangement will influence the overall 
outcome of the genetic modification. A knowledge of the normal toxin production in the 
plant and the effect on it of various growth and culturing conditions, to which the GM 
plant is subjected, as well as knowledge whether the new gene product appears in the 
final food, is essential. The same reasoning applies to nutritionally important 
components especially in food plants. 
Essential steps of the safety evaluation are therefore: 
• characterisation of the parent food organism; 
• characterisation at the molecular level of the nature of the genetic modification 
including insertional position, copy number and biochemical expression level; 
• establishment, as far as possible, of substantial equivalence between the parent 
food organism and its new derivative through chemical and phenotypic analysis; 
• if substantial equivalence cannot be established, conventional safety studies on 
specific chemicals occurring in the food due to the phenotypic changes involving 
either the new product of the new gene or the safety of inherent natural toxins 
now present in altered amounts. The potential allergenicity of the new components 
also needs to be addressed. 
GM animals. The general principles established for the safety evaluation of GM plants 
apply also to GM animals. The safety assessment will initially address the establishment 
of substantial equivalence between the parent organism and the GM organism focussing 
on primary and secondary effects of the genetic modification process. For example if the 
modification is directed towards changing the globulins in cow's milk to a more 
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"human" type, the new globulins have to be assessed. Another example may be a fish 
genetically modified to produce an antifreeze protein. The safety of this chemical 
modification can be evaluated by conventional toxicological strategies and should also 
include an assessment of the allergenicity aspects. 
GM microorganisms. In compliance with the provisions set out for GM plants and GM 
animals, the parent microorganism, which is the subject of genetic modification has a 
priori to be recognized either as a microrganism with a tradition in food fermentation in 
the EU, as a non-pathogenic, biologically advantageous human intestinal commensal, or 
as a traditionally used production organism for foods, including food additives and 
technical aids, to simplify the evaluation procedure. In other cases, not only the genetic 
modification but also the parent microorganism needs to be assessed as being novel. 
V. Genetic stability of the GMO used as NF source 
The question concerning genetic stability relates to the structural and local maintenance 
of the introduced genetic material and to the gene expression in the GMO. 
VI. Specificity of expression of novel genetic material 
This scheme relates to the factors involved in regulation of gene expression, for instance 
organ/tissue specificity, conditions of repression and activation. 
VH. Transfer of genetic material from GMO 
Based on current knowledge, considerations of gene transfer from GMO in the human 
gut focus on microorganisms. Horizontal gene transfer among microorganisms is well 
established and has therefore to be considered in food safety assessments. One aspect of 
biological containment is the possible transfer of genetic material from GM 
microorganisms to the human gut microflora. There are different possibilities for 
addressing this aspect in an experimental setting, e.g. animal or in vitro gut models. 
In assessing the food safety consequences of gene transfer, the nature of the gene and its 
product, the frequency of the transfer, and the level of expression in transformed gut 
microorganisms should be taken into account. Transfer of genes from plants to 
microorganisms is a theoretical possibility; the consequences of such an event should be 
considered. 
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VIII. Ability of the GMM to survive in and colonise the human gut 
The genetic modification might facilitate survival during passage through the intestines 
and colonization of the human gut. Antagonistic and synergistic effects on the 
composition of the intestinal flora may occur and have an influence on human health. 
Therefore, experimental data are required on the respective properties of the GMO. 
For living GMM in food attention should particularly focus on their capability to survive 
in and colonize the gastrointestinal tract and to maintain their genomic stability. For this 
assessment in vitro and in vivo gut models mimicking the human situation as closely as 
possible may be needed. Aspects relating to pathogenicity and gastrointestinal immunity 
need special consideration. 
LX. Anticipated intake/extent of use of the NF 
Projections of anticipated intakes are needed to evaluate the dietary and nutritional 
significance of NF. This assessment will naturally draw upon information on the nature 
of the NF and its anticipated uses based upon its properties e.g. as a fat replacer. 
X. Information from previous human exposure to the NF or its source 
Documentation on previous use of the NF source in the EU or the NF source and /or the 
NF in other parts of the world is important to establish a baseline for assessment. 
However, history of food use outside the EU is not of itself a guarantee that the NF can 
be safely consumed in the EU. The information should deal with such aspects, where 
traditional handling and preparation of the plant, animal or microorganism prevent 
misuse or adverse short and long term health effects, for example those due to inherent 
antinutritional/toxic factors. In many cases, necessary precautions are reflected in the 
corresponding regional and cultural habits. 
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XI. Nutritional information on the NF 
The overall assessment should, as indicated above, include a systematic review of the 
NF's composition, preparation and role which it is expected to have in the diet. Such an 
assessment with a review of relevant published material would enable an appraisal of 
substantial equivalence to a traditional food or food component. 
If substantial equivalence cannot be established appropriate preliminary assessments 
should be made in animal models to establish some aspects of nutritional quality but full 
nutritional assessment needs to be done in human subjects. Such studies should be based 
on well defined hypotheses with clear nutritional and metabolic outcomes relevant to the 
NF, to its dietary context, and to the anticipated consumer group. 
Nutritional consequences should be assessed at normal and maximum levels of 
consumption, and the nutrient compositional data should take into account the effects of 
storage, further processing and cooking. The effect of antinutritional factors (e.g. 
inhibiting mineral absorption or bioavailability) on the nutritional value of the whole diet 
should also be assessed. 
The numbers involved in study groups should ensure that the study has adequate 
statistical power. All studies should comply with relevant elements and ethical principles 
of guidelines on Good Clinical Practice and Good Laboratory Practice. 
In some circumstances it is envisaged that plans should be provided for post-market 
surveillance for possible long term effects of the NF. 
XII. Microbiological information on the NF 
In addition to toxicological and nutritional safety wholesomeness of a NF embraces 
microbiological safety. Generally, the intentionally used source organism for the NF has 
to be recognised as a non-pathogenic, non-toxigenic microorganism of known genetic 
stability which does not affect the desirable properties of the normal intestinal flora. The 
examination of a NF should include a characterization of the microorganisms present 
and the analysis of their metabolites. 
ΧΙΠ. Toxicological information on the NF 
This scheme covers the set of toxicological information needed to assess the NF. The 
range of scenarios can extend from foods for which substantial equivalence can be 
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established to foods for which substantial equivalence cannot be established and which, 
therefore, require an appropriate nutritional-toxicological testing program. 
If substantial equivalence to a traditional counterpart cannot be established, the safety 
assessment based on a case-by-case evaluation must consider the following elements: 
• consideration of the possible toxicity of the analytically identified individual 
chemical components; 
• toxicity studies in vitro and in vivo including mutagenicity studies, reproduction 
and teratogenicity studies as well as long term feeding studies, following a tiered 
approach on a case-by-case basis; 
• studies on potential allergenicity. 
In the case of novel microconstituents and isolated novel food components, which differ 
by identifiable characteristics from traditional foods or for defined novel products 
obtained from genetically modified organisms, it is possible to restrict testing to only 
those products or substances rather than the whole NF. In some cases, the testing of the 
novel property would have only marginal nutritional implications for laboratory animals 
so that the traditional toxicological approach can be applied for establishing safety. 
Most of the defined chemical substances can probably be tested for their safety similarly 
to food additives by utilising conventional methods of safety evaluation as described in 
the SCF Report No. 10. This implies the use of conventional toxicological testing 
procedures applied in a tiered sequence. This would involve initial mutagenicity studies 
and an appropriate feeding study in a rodent species with an exhaustive investigation of 
all relevant toxicological parameters. Furthermore, if warranted by structural or 
exposure considerations, additional investigations should be undertaken covering all the 
usual toxicological endpoints including metabolism, toxicokinetics, chronic toxicity/ 
carcinogenicity, reproductive function, teratogenicity, and possibly neurotoxicity and 
immunotoxicity. 
Novel macroconstituents or NF which are not substantially equivalent to traditional 
counterparts will require a testing programme depending on the toxicological concerns 
raised. In general, this programme should include at least a 90 day feeding study in a 
rodent species, whereby special attention is paid to the choice of doses and the 
avoidance of problems of nutritional imbalance. These constraints may require a 
different way of conducting toxicological studies and interpreting their results (see 3.6). 
The potential for mutagenicity needs investigation. Any in vitro mutagenicity studies will 
need to cover the usual major endpoints. Special technical problems may be encountered 
in testing novel macroconstituents in in vitro mutagenicity test systems, particularly 
because of effects of the NF or its constituents on the growth medium, the test cells or 
52 Reports of the Scientific Committee for Food (Thirty-ninth Series) 7 JUNE 1996 NOVEL FOODS AND NOVEL FOOD INGREDIENTS 
the test organisms, unrelated to mutagenicity. There may be cases where feeding studies 
in a second species and an investigation of effects on the composition of the intestinal 
flora are needed. Also chronic toxicity/carcinogenicity studies may be necessary. The 
allergenic potential needs also to be investigated. 
Review of recommendations 
The area of novel foods is developing rapidly. The science and technology is making 
enormous advances and many countries and international organisations are elaborating 
procedures and guidelines for the safety assessment of novel foods. In the light of these 
developments, and of experiences gained in applying its current recommendations, the 
SCF will reconsider these recommendations after five years. 
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8 Glossery 
This glossary is intended to explain the way in which various terms are used by the SCF 
in its recommendations rather than to provide precise scientific definitions. 
Copy number: the number of times a particular coding sequence is present in 
the genome 
DNA: deoxyribonucleic acid, which is present in all living cells and 
contains the information for cellular structure, organisation and 
function 
Donor: organism from which genetic material has been obtained for 
subsequent transfer 
Epitope: distinct region of an antigen which is recognized by the 
combining site of an antibody 
Expression: manifestation of a characteristic that is specified by a gene 
Food allergy: adverse immune (IgE)-mediated reactions to foods occurring in 
susceptible individuals 
Gene: smallest portion of a DNA molecule that contains sufficiënt 
heritable information to code for a particular trait or function of 
an organism 
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Food allergy: adverse immune (IgE)-mediated reactions to foods occurring in 
susceptible individuals 
Gene: smallest portion of a DNA molecule that contains sufficient 
heritable information to code for a particular trait or function of 
an organism 
Genetic modification: alteration of genetic material using the techniques defined in 
Directive 90/220/EEC 
Genetically modified 
organism (GMO): 
Genetic stability: 
Genome: 
Host: 
Immunoassay: 
Insertion: 
Organism: 
Plasmid: 
Position effect: 
Vector: 
an organism in which the genetic material has been altered in a 
way that does not occur naturally by mating and/or natural 
recombination 
the degree to which the genetic make-up of an organism is 
inherited unaltered by subsequent generations 
the total of the genes of an organism 
organism into which heritable genetic material prepared 
elsewhere has been introduced 
method of measuring using antibodies to detect concentrations 
of unknown substances 
addition of one or more nucleotide base pairs into a DNA 
molecule 
any biological entity capable of replication or of transferring 
genetic material 
circular piece of extrachromosomal DNA in bacteria and certain 
other organisms, capable of replicating independently of the 
chromosome 
unintentional effect caused by the insertion of a gene which 
interferes with the normal function of another gene 
self-replicating DNA molecule modified to transfer a foreign DNA 
segment into the host genome 
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Table I: Association between the categorization in the EU Regulation on Novel Foods and Novel Food 
Ingredients and the SCF recommendations 
EU Regulation Art. 1 (2) 
Class 1 
Class 2 
Class 3 
Class 4 
Class 5 
Class 6 
Pure chemicals or simple mixtures from non-GM 
sources 
Complex NF from non-GM sources 
GM plants and their products 
GM animals and their products 
GM microorganisms and their products 
Foods produced using a novel process 
a 
X 
X 
X 
b 
X 
X 
X 
c 
Χ 
d 
Χ 
Χ 
c 
Χ 
Χ 
f 
χ 
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Table Π: 
to structured schemes to be followed for each class of NF 
Index 
I. 
II. 
III. 
IV. 
V. 
VI. 
VII 
VII 
I. 
IX 
X. 
XI. 
XII 
XII 
I 
Class of NF 
Structured scheme 
Specification of the NF 
Effect of the production process 
applied to the NF 
History of the organism used as 
the source of the NF. 
Effect of the genetic modification 
on the properties of the host 
organism 
Genetic stability of the GMO 
Specificity of expression of novel 
genetic material 
Transfer of genetic material from 
GM microorganisms 
Ability to survive in and colonise 
the human gut 
Anticipated intake/extent of use 
oftheNF 
Information from previous 
human exposure to the NF or its 
source 
Nutritional information on the 
NF 
Microbiological information on 
theNF 
Toxicological information on the 
NF 
1.1 
X 
X 
X 
X 
X 
X 
X 
X 
1.2 
X 
X 
X 
X 
X 
X 
X 
2.1 
X 
X 
X 
X 
X 
X 
X 
X 
2.2 
X 
X 
X 
X 
X 
X 
X 
3.1 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
3.2 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
4.1 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
4.2 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
5.1 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
5.2 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
6 
X 
X 
X 
X 
X 
X 
X 
X 
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Specification of the NF 
Depending on the derivation and 
composition of the NF, is 
appropriate analytical 
information available on 
potentially toxic inherent 
constituents, external 
contaminants and nutrients? 
no -> 
Seek further information then 
reappraise using scheme I. 
ves 
Ψ 
Is the information representative 
of the NF when produced on a 
commercial scale? 
no -> 
Seek further information then 
reappraise using scheme I. 
yes 
Is there an appropriate 
specification (including species, 
taxon etc. for living organisms) to 
ensure that the NF marketed is 
the same as that evaluated? 
no -> 
Develop specification then 
reappraise using scheme I. 
ves 
'ψ 
Sufficient information from 
scheme I. 
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II. EFFECT OF THE PRODUCTION PROCESS 
APPLIED TO THE NF 
Sufficient information 
from scheme II. 
<- no 
yes 
Sufficient information 
from scheme II. Scheme 
XII discusses 
requirements for 
microbiological 
information. 
Identify appropriate 
controls and reappraise 
using scheme II. 
After processing is the 
NF likely to contain 
microorganisms of 
adverse public health 
significance? 
Sufficient information 
from scheme II. 
Schemes XI, XII and 
XIII discuss 
requirements for 
nutritional, 
microbiological and 
toxicological 
information. 
yes 
yes 
Has the process the 
potential to alter the 
levels in the NF of 
substances with an 
adverse effect on public 
health? 
yes 
After processing is the 
NF likely to contain 
microorganisms of 
adverse public health 
significance? 
no 
Ψ 
Sufficient information 
from scheme II. 
Schemes XI and XIII 
discuss requirements for 
nutritional and 
toxicological 
information. 
Does the NF undergo a 
production process? 
yes 
Ψ 
Is there a history of use 
of the production process 
for the food? 
yes 
Ψ 
Sufficient information 
from scheme II 
no -> 
no -> 
Sufficient information 
from Scheme II. 
Does the process result 
in a significant change 
in the composition or 
structure of the NF 
compared to its 
traditional counterpart? 
Seek further information 
then reappraise using 
scheme II. 
71 
no 
yes -> 
no 
\¿ 
Sufficient information 
from Scheme II. 
Is information available 
to enable identification 
of the possible 
toxicological, nutritional 
and microbiological 
hazards arising from use 
of the process? 
yes 
Ψ 
Are the means identified 
for controlling the 
process to ensure that the 
NF complies with its 
specification? 
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III. HISTORY OF THE ORGANISM USED AS THE SOURCE 
OF THE NF 
Is the NF obtained from 
a biological source, i.e. a 
plant, animal or 
microorganism? 
yes 
Ψ 
Has the organism used 
as the source of the NF 
been derived using GM? 
no 
Ψ 
I 
s the source organism 
characterised? 
yes 
Ψ 
Is there information to 
show that the source 
organism and/or foods 
obtained from it are not 
detrimental to human 
health? 
no -> 
yes -> 
no -> 
yes -> 
Suficient information 
from Scheme III. 
Is the source of the NF a 
microorganism? 
Characterise the source 
organism then reappraise 
using scheme III. 
Sufficient information 
from scheme III. 
yes -> 
no 
il 
Sufficient information 
from scheme III. 
Schemes IV, V, VI, VII 
and VIII discuss 
information 
requirements for GM 
microorganisms. 
Sufficient information 
from scheme III. 
Schemes IV, V and VI 
discuss information 
requirements for GM 
plants and animals. 
no 
Ψ 
Is there information on 
the mean levels and 
ranges of the detrimental 
substances in NF derived 
from the organism? 
yes -> 
Does the information 
reflect extremes in 
production and 
processing conditions for 
theNF? 
yes 
yes -> 
Is the information 
sufficient to assess 
potential consumer risk? 
no 
Ψ 
no 
4/ 
no 
Ψ 
Seek further information 
then reappraise using 
scheme ΠΙ. 
Seek further information 
then reappraise using 
scheme III. 
Sufficient information 
from scheme III. 
Schemes XI and XIII 
discuss requirements for 
nutritional and 
toxicological 
information. 
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IV. EFFECT OF THE GENETIC MODIFICATION ON THE 
PROPERTIES OF THE HOST ORGANISM 
Has the host organism 
used for the GM a 
history of safe food use 
in the EU? 
yes 
Ψ 
Are any differences 
between the GM 
organism and the host 
solely the intended result 
of the GM? 
yes 
Ψ 
Are there differences of 
nutritional, 
microbiological or 
toxicological 
significance, bearing in 
mind the way in which 
the NF will be processed 
before consumption? 
yes 
Ψ 
Sufficient information 
from scheme IV. 
Schemes XI, XII and 
XIII discuss 
requirements for 
nutritional, 
microbiological and 
toxicological 
information. 
no -> 
no -> 
no -> 
Sufficient information 
for scheme IV Schemes 
XI, XII and XIII discuss 
requirements for 
nutritional, 
microbiological and 
toxicological 
information. 
Is there sufficient 
information to show that 
the results of any 
secondary effects of the 
GM are of no nutritional, 
microbiological and 
toxicological 
significance? 
yes 
Ψ 
Sufficient information 
from scheme IV 
no -> 
Sufficient information 
from scheme IV 
Schemes XI, XII and 
XIII discuss 
requirements for 
nutritional, 
microbiological and 
toxicological 
information. 
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GENETIC STABILITY OF THE GMO USED AS NF SOURCE 
Does the information 
available demonstrate 
the stability of the GM 
organism under 
anticipated conditions of 
use? 
no 
Does the information 
show that instability 
results in reversion to the 
organism used as host 
for the GM? 
no 
Is information available 
to show the safe use of 
the product(s) resulting 
from genetic instability 
in food production? 
yes 
Sufficient information 
from scheme V. 
yes -> 
yes -> 
no -> 
Sufficient information 
from scheme V. 
Is information available 
to show the safe use of 
the host organism in 
food production? 
no 
Ψ 
Seek further information 
then reappraise using 
scheme V. 
yes ->  Sufficient information 
from scheme V. 
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VI. SPECIFICITY OF EXPRESSION OF NOVEL GENETIC 
MATERIAL 
Is there information to 
demonstrate specificity 
of expression of novel 
genetic material under 
all pertinent conditions 
and stages of growth of 
the GM organism? 
ves 
Φ 
Does the information 
show that inserted genes 
are not expressed in 
parts of the GM 
organism intended for 
food use? 
yes 
Φ 
Sufficient information 
from scheme VI. 
no -> 
no -> 
Has information on the 
nutritional, 
microbiological and 
toxicological aspects of 
the NF been obtained on 
the basis that any novel 
gene products are 
present throughout the 
GM organism? 
no 
Φ 
Sufficient information 
from scheme VI. 
Schemes XI, XII and 
XIII discuss 
requirements for 
nutritional, 
microbiological and 
toxicological 
information. 
yes ->  Sufficient information 
from scheme VI. 
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VII. TRANSFER OF GENETIC MATERIAL FROM GMO 
Does the NF contain 
DNA? 
no ->  Sufficient information 
from scheme VII. 
ves 
"φ 
Is the NF a GM 
microorganism or 
derived from a GM 
microorganism? 
no ->  Sufficient information 
from scheme VII. 
yes 
Φ 
Is there information to 
show the probability of 
the transfer of inserted 
genetic material to 
human gut microflora 
under normal or stressed 
conditions? 
no ->  Seek further information 
then reappraise using 
scheme VII. 
yes 
Φ 
Is there information to 
allow an assessment to 
be made of the 
significance for human 
health if transfer of 
inserted genetic material 
to human gut microflora 
does occur under normal 
or stressed conditions? 
yes ->  Sufficient information 
from scheme VII. 
no 
Φ 
Seek further information 
then reappraise using 
scheme VII. 
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VIII. ABILITY OF THE GMM TO SURVIVE IN AND COLONISE THE 
HUMAN GUT 
Does the NF contain 
DNA? 
yes 
Φ 
Is the host strain for the 
GM a human pathogen? 
no 
Φ 
Is there information to 
show that the GM 
microorganism is 
intended to colonise the 
human gut? 
no 
Φ 
Is there information to 
show that the GM 
microorganism does not 
survive in and colonise 
the human gut? 
ves 
Φ 
Is there information to 
show that there are no 
observable adverse 
effects on existing gut 
flora populations? 
yes 
Φ 
Sufficient information 
from scheme VIII. 
no -> 
yes -> 
yes 
no -> 
yes 
no -> 
Sufficient information 
from scheme VIII. 
Sufficient information 
from Scheme VIII. 
Is there information to 
show that no foreign 
genes of adverse public 
health significance are 
expressed? 
Seek further information 
then reappraise using 
scheme VIII. 
no ->  Seek further information 
then reappraise using 
scheme VIII. 
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IX. ANTICIPATED INTAKE/EXTENT OF USE OF THE NF 
Is there information on 
the anticipated uses of 
the NF based on its 
properties? 
no -> 
Sufficient information 
from scheme IX. 
yes 
Φ 
Is there information to 
show anticipated intakes 
for groups predicted to 
be at risk? 
no -> 
Seek further information 
then reappraise using 
scheme IX. 
yes 
Φ 
Will introduction of the 
NF be restricted 
geographically? 
yes -> 
Do intake figures reflect 
this limited distribution 
oftheNF? 
no -> 
Seek further information 
then reappraise using 
scheme IX. 
no 
Φ 
yes 
Will the NF replace 
other foods in the diet? 
no ->  Sufficient information 
from scheme IX. 
yes 
Φ 
Are any of the replaced 
foods significant 
nutritional sources? 
no -> 
Sufficient information 
from scheme IX. 
yes 
Φ 
Does the probable level 
of substitution have a 
nutritional significance 
for any population 
groups? 
yes -> 
Sufficient information 
from scheme IX. 
Scheme XI discusses 
requirements for 
nutritional information. 
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X. INFORMATION FROM PREVIOUS HUMAN 
EXPOSURE TO THE NF OR ITS SOURCE 
Is there information 
from previous direct, 
indirect, intended or 
unintended human 
exposure to the NF or its 
source which is relevant 
to the EU situation with 
respect to production, 
preparation, population, 
lifestyles and intakes? 
yes 
Φ 
Is there information to 
demonstrate that 
exposure to the NF is 
unlikely to give rise to 
nutritional, 
microbiological, 
toxicological and/or 
allergenicity problems? 
no 
Φ 
Sufficient information 
from scheme IX. 
Schemes XI, XII and 
XIII discuss 
requirements for 
nutritional, 
microbiological and 
toxicological 
information. 
no -> 
yes -> 
Seek further information 
then reappraise using 
scheme X; if information 
is not available schemes 
XI, XII and XIII discuss 
requirements for 
nutritional, 
microbiological and 
toxicological 
information. 
Sufficient information 
from scheme X. 
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XI. NUTRITIONAL INFORMATION ON THE NF 
Is there information to 
show that the NF is 
nutritionally equivalent 
to existing foods that it 
might replace in the 
diet? 
no 
Φ 
Is there information to 
show that the NF does 
not affect the 
bioavailability of 
nutrients from the diet or 
have any adverse 
physiological effects? 
ves 
Φ 
Is there information to 
allow an assessment to 
be made of the 
nutritional impact of the 
introduction of the NF? 
no 
Φ 
Seek further information 
then reappraise using 
scheme XI. 
yes -> 
no -> 
yes 
yes -> 
Sufficient information 
from scheme XI. 
Is information available 
to allow a balance to be 
made between risks and 
benefits? 
Sufficient information 
from scheme XI. 
no -> 
Seek further information 
then reappraise using 
scheme XI. 
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XII. MICROBIOLOGICAL INFORMATION ON THE NF 
Is the presence of any 
microorganisms or their 
metabolites due to the 
novelty of the 
product/process? 
yes 
Φ 
Is there information to 
show that the NF is 
unlikely to contain 
microorganisms and/or 
their metabolites of 
adverse public health 
significance? 
no 
Φ 
Is the NF likely to be 
confused with existing 
foods? 
ves 
φ 
Are the procedures for 
handling, cooking or 
processing the existing 
food adequate to ensure 
safety if applied to the 
NF? 
no -> 
yes -> 
no -> 
71 
no 
yes -> 
Sufficient information 
from scheme XII. 
Sufficient information 
from scheme XII. 
Is information available 
to allow the development 
of procedures to ensure 
that the NF is 
appropriately handled, 
cooked or processed 
before consumption? 
ves 
φ 
Sufficient information 
from scheme XII. 
no -> 
Seek further information 
then reappraise using 
scheme ΧΠ. 
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XIII. TOXICOLOGICAL INFORMATION ON THE NF 
Is there a traditional 
counterpart to the NF 
that can be used as a 
baseline to facilitate the 
toxicological 
assessment? 
yes 
Φ 
Compared to the 
traditional counterpart, 
does the NF contain new 
toxicants or changed 
levels of existing 
toxicants? 
no >> 
no -> 
Is there information 
from a range of 
toxicological studies 
appropriate to the NF to 
show that the NF is safe 
under anticipated 
conditions of preparation 
and use? 
ves 
'φ 
Is there information 
which suggests that the 
NF might pose an 
allergenic risk to 
humans? 
no -> 
no -> 
Seek further information 
then reappraise using 
scheme XIII. 
Sufficient information 
from scheme XIII. 
ves 
"φ 
Are the levels in the NF 
of these new toxicants or 
existing toxicants no 
higher than those found 
in other foods with a 
history of food use in the 
EU? 
no 
Φ 
Is there information to 
show that the presence of 
these toxicants in the NF 
will not be a cause for 
yes -> 
yes-> 
Seek further information 
then reappraise using 
scheme ΧΙΠ. 
-r· 
no 
Is there information to 
show that the 
consumption of the NF 
will not raise intakes of 
the toxicants to 
unacceptable levels? 
yes 
Φ 
Is there information 
which suggests that the 
NF might pose an 
allergenic risk to 
humans? 
4- no 
Is there sufficient 
information to allow the 
potential allergenicity of 
the NF to be monitored? 
yes 
Φ 
Has the level of 
allergenicity been 
determined in controlled 
trials? 
ves 
Φ 
no -> 
Sufficient information 
from scheme ΧΙΠ. 
Seek further information 
then reappraise using 
scheme XIII. 
70  Reports of the Scientific Committee for Food (Thirty-ninth Series) PRINCIPLES FOR THE DEVELOPMENT OF MICROBIOLOGICAL 
CRITERIA FOR FOODSTUFFS AS COVERED BY THE HYGBENE OF 
FOODSTUFFS DIRECTIVE 93/43/EEC ( 1) 
RECOMMENDATION OF THE SCIENTIFIC COMMITTEE FOR FOODS 
(EXPRESSED ON 7 JUNE 1996) 
Terms of reference 
To prepare for the Commission guidance on the principles to be considered when 
assessing the potential food hazards caused by micro-organisms and their toxins in 
foodstuffs and the scientific basis for the development of microbiological criteria in 
certain classes of foodstuffs under Article 4 of the Hygiene of Foodstuffs Directive 
93/43/EEC 
To assess in accordance with such principles or guidelines adopted by the SCF the 
extent of the microbial hazards in foods 
Background 
1.1. This document has been produced by the Scientific Committee for Food and 
recommends to the Commission the scientific principles that should be taken into account 
when developing microbiological criteria for foodstuffs. 
1.2. It describes the broad scientific framework within which consideration of the 
development of microbiological criteria should take place. It recommends that a 
microbiological criterion should be based on scientific analysis and advice together with an 
assessment of the risk appropriate to the foodstuff and its use. (2,3) 
1.3. The analysis of risk from biological agents and in particular microbiological agents, is 
very much a developing area and as such it is recommended that further consideration is given 
to this within the framework of the Scientific Committee for Food, taking into account the 
work being undertaken by the Scientific Co-operation task on Microbiological Risk 
Assessment according to Directive 93/5/EEC(4). 
1.4. The scientific principles recommended in this document can be applied generally to the 
development of all microbiological criteria for foods. However they are specifically 
recommended to the Commission for application to those foodstuffs and parts of the food 
chain covered by the Hygiene of Foodstuffs Directive 93/43/EEC. These principles are not 
designed or intended to be used for investigative work. 
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1.5. The Hygiene of Foodstuffs Directive 93/43/EEC (Article 4) states that without 
prejudice to more specific Community rules, microbiological criteria and temperature control 
criteria for certain classes of foodstuffs may be adopted within the framework of the Standing 
Committee for Foodstuffs after consultation with the Scientific Committee for Food, following 
the procedure in Article 14. 
1.6. Fundamental to the application of this directive is the utilisation of the principles of the 
Hazard Analysis Critical Control Point System (HACCP). The safety of foods is principally 
assured through control at the source, the use of Guides to Good Hygiene Practice and the 
application of HACCP principles, during production, processing, handling, distribution, 
storage and sale. 
1.7. The analysis of foods for compliance with mandatory microbiological criteria must be 
undertaken in an official laboratory in compliance with the Official Control of Foodstuffs 
Directive( 5), and The Additional Measures Concerning the Official Control of Foodstuffs 
Directive( 6). 
DEFINITION OF A MICROBIOLOGICAL CRITERION FOR FOODS 
A microbiological criterion for food defines the acceptability of a process, 
product or food lot based on the absence or presence, or number of 
microorganisms, and/or quantity of their toxins/metabolites, per unit(s) of mass, 
volume or area. 
3. COMPONENTS OF MICROBIOLOGICAL CRITERIA FOR FOODS 
3.1. A microbiological criterion consists of: 
• a statement of the microorganisms of concern and/or their toxins/ metabolites and 
the reason for that concern in the product; 
• the methods for their detection and/or quantification; 
• a plan defining the number of field samples to be taken, the size, and 
characteristics of the sample and analytical unit; 
• microbiological limits considered appropriate to the food at the specified point(s) 
of the food chain; 
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• the number of analytical units that should conform to these limits; 
3.2. A microbiological criterion should also state: 
• the food(s) to which the criterion applies, 
• the point(s) in the food chain where the criterion applies, 
• the actions to be taken when the criterion is not met. 
4. RECOMMENDATIONS ON THE DEVELOPMENT AND APPLICATION 
OF MANDATORY MICROBIOLOGICAL CRITERIA FOR FOODS 
4.1 The emphasis in the Hygiene of Foodstuffs Directive is placed on the use of preventive 
actions and the utilisation of the principles of HACCP to assure the microbiological safety of 
food at the point of consumption. This reduces the justification for a reliance on 
microbiological testing of foods for this purpose. 
4.2 The development of mandatory microbiological criteria should be limited to those 
products and/or points of the food chain where their use is effective and the degree of 
protection offered to the consumer can be considered to be improved by using this type of 
tool. 
4.3 Where consideration has been given to the above and the need for a mandatory 
microbiological criterion has been identified, it's development should take into account as 
much scientific data and information as possible relating to a risk assessment. The resulting 
criterion should be product-type specific and only applied at the point of the food chain stated. 
4.4. Priority for the development of mandatory microbiological criteria should be given to 
those micro-organisms, their toxins or metabolites in foods where a risk assessment has 
established a hazard to the consumer. 
4.5. Microbiological testing may be used by control officiais and/or food businesses 
operators to determine the microbiological safety and wholesomeness of raw materials, 
ingredients, products and food lots particularly those of unknown or uncertain origin. Testing 
can also be used to establish whether good hygienic practices have been applied and provide 
information on the efficacy of a business's food safety management system. 
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4.6. In these cases, mandatory microbiological criteria may be applied to define the 
acceptability of raw materials, ingredients, products, food lots, and processes by control 
officials and/or food business operators based on an evaluation of the risk to the consumer. 
4.7. Depending on the results of an evaluation of the risk to the consumer the official 
control actions may be sorting, reprocessing, rejection or destruction of product, and/or 
further investigation. The actions to be taken by control officials, where a microbiological limit 
stated in the criteria has been exceeded should be appropriate for the safety and proportionate 
to the risk to the consumer. 
4.8. Microbiological criteria used for contractual purposes by food businesses, to assess the 
acceptability of raw materials, ingredients, intermediate or finished products as part of their 
own safety management system should not be confused with legal requirements for official 
control purposes. 
5. FACTORS TO CONSTDER WHEN ESTABLISHING AND APPLYING 
MICROBIOLOGICAL CRITERIA 
5.1. The hygiene and safety of foods to which directive 93/43/EEC on the Hygiene of 
Foodstuffs applies should be ensured through the application of the requirements of the 
directive relating to good hygienic practices and the development and implementation of the 
principles of HACCP contained in Article 3. 
5.2. A microbiological criterion should be established and applied only where there is a 
definite need for it and where it can be shown to be effective and practical. Such need is, for 
example, demonstrated by epidemiological evidence that the food under consideration may 
represent a public health hazard and that a criterion is meaningful for the protection of the 
consumer, or by the results of a risk assessment. It should be technically attainable by 
applying good manufacturing practice, and be realistic in terms of achievability. 
5.3. To fulfil the purposes of microbiological criteria, consideration should be given to: 
• evidence of risk to health; 
• the microbiological status of the raw material(s); 
• the effect of processing on the microbiological status of the food; 
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• the likelihood and consequences of microbial contamination and/or growth during 
subsequent handling, storage and use; 
• the categories of consumers concerned; and 
• the cost/benefit of applying such a criteria. 
5.4. The number and size of analytical units per product or food lot tested should be stated 
in the sampling plan and should not be modified. A product or food lot should not be 
subjected to repeat testing, in order to establish compliance with a microbiological criterion. 
5.5. . The microbiological tests applied, the limits and the point in the food chain assessed 
should be appropriate, practical and provide as much information as possible about the safety 
of the food at the point of consumption. 
6. MICROBIOLOGICAL ASPECTS OF CRITERIA 
6.1. Microorganisms and toxins of importance in a particular food. 
6.1.1. For the purpose of this document microorganisms and toxins include: 
• bacteria, viruses, yeasts, and moulds and algae, 
• parasitic protozoa,
3 
• their toxins/metabolites. 
6.1.2. The microorganisms included in a criteria should be widely accepted as relevant as 
pathogens or as indicator organisms to the particular food and food business operation. 
6.1.3. The mere finding, with a presence or absence test of certain organisms known to cause 
foodborne illness may not necessarily indicate a hazard, the relevance of their presence should 
relate to the results of the risk assessment. 
6.1.4. Where pathogens can be detected directly and reliably consideration should be given to 
testing for them in preference to indicator organisms. If a test for an indicator organism is 
applied there should be a clear statement as to whether the test is used to indicate an 
unsatisfactory hygiene practice or the possible presence of a health hazard. 
Helminths may be considered in specifications when appropriate 
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6.2. Microbiological methods. 
6.2.1. Preference should be given to reference methods developed under the aegis of an 
European Standards Institute which have already been validated for the commodity concerned. 
When this is not possible, only methods for which the reliability (accuracy, reproducibility, 
inter- and intra-laboratory variation) has been statistically established in comparative or 
collaborative studies in several laboratories should be used in the microbiological criterion. 
6.2.2. Methods used to determine the suitability for consumption of highly perishable foods, 
or foods with a short shelf-life, should be chosen such that the results of microbiological 
examinations are available before the foods are consumed or exceed their shelf-life. 
6.2.3. The microbiological methods specified should be reasonable with regard to complexity, 
availability, ease of interpretation, time required and costs. 
6.2.4. Methods which are applicable to various groups of commodities should be given 
preference over methods which apply only to individual commodities. 
6.3. Microbiological limits. 
6.3.1. Limits used in criteria should be based on microbiological data appropriate to the food 
and should be applicable to a variety of similar products. They should therefore be based on 
data gathered over as wide a range of situations as possible and where good hygienic practices 
are in operation. 
6.3.2. In the establishment of microbiological limits, changes in the microflora which could 
result from likely storage and distribution practices should be taken into account. For the 
development of mandatory microbiological criteria within the terms of directive 93/43/EEC, 
when appropriate, the conditions under which the food is expected to be handled and 
consumed. 
6.3.3. Numerical limits should also take account of the likelihood of uneven distribution of 
microorganisms in the food and the inherent variability of the analytical procedure. 
6.3.4. It should be borne in mind that no feasible sampling plan can ensure complete absence 
of a particular organism in a product or food lot. 
76 Reports of the Scientific Committee for Food (Thirty-ninth Series) 7 JUNE 1996 MICROBIOLOGICAL CRITERIA FOR FOODSTUFFS 
7. SAMPLING PLANS, METHODS AND HANDLING 
7.1. A sampling plan is the particular choice of a sampling procedure and the decision 
criteria to be applied to a lot, based on examination of a prescribed number of analytical 
sample units by defined methods. Sampling plans should be administratively and economically 
feasible. 
In particular, sampling plans should take into account: 
• consideration of the severity of the hazard and an assessment of the risk 
• the heterogeneity of distribution of microorganisms, 
• the statistical probability of detecting unacceptable food lots, or rejecting 
acceptable food lots. 
For many applications 2- or 3-class attribute plans may prove useful.( 7) 
7.2. The sampling method should be defined in the sampling plan, the time between taking 
the field samples and analysis should be as short as possible. During transport to the laboratory 
the conditions (e.g. temperature) should be appropriate to the food, so that the results reflect -
within the limitations given by the sampling plan - the microbiological conditions of the lot, or 
food product. 
8. REPORTING 
8.1. The test report shall give the information needed for complete identification of the 
sample, the sampling plan, the test methods, the results, and their interpretation. 
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